Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AASS 2.59 0 -1.35 5.0E-5 MirTarget; miRanda -0.3 0 NA
2 hsa-miR-590-3p ABAT 2.59 0 -0.34 0.43051 PITA; miRanda -0.27 0.00042 NA
3 hsa-let-7a-3p ABCA1 1.42 0 -0.71 0.00276 mirMAP; miRNATAP -0.28 0 NA
4 hsa-miR-361-5p ABCA1 0.97 0 -0.71 0.00276 miRanda; mirMAP -0.32 0 NA
5 hsa-miR-590-3p ABCA6 2.59 0 -2.84 1.0E-5 MirTarget; miRanda -0.47 2.0E-5 NA
6 hsa-miR-361-5p ABCA8 0.97 0 -5.33 0 miRanda -0.7 0.00034 NA
7 hsa-miR-590-3p ABCA8 2.59 0 -5.33 0 miRanda -0.89 0 NA
8 hsa-miR-590-3p ABCA9 2.59 0 -3.14 0 miRanda -0.71 0 NA
9 hsa-miR-590-3p ABCB1 2.59 0 -2.33 0 miRanda -0.29 1.0E-5 NA
10 hsa-miR-590-3p ABCB4 2.59 0 -1.92 0 miRanda -0.4 0 NA
11 hsa-let-7a-3p ABCC4 1.42 0 -1.54 1.0E-5 mirMAP -0.19 0.01906 NA
12 hsa-miR-590-3p ABCC4 2.59 0 -1.54 1.0E-5 mirMAP -0.25 2.0E-5 NA
13 hsa-let-7a-3p ABCC9 1.42 0 -2.76 0 mirMAP -0.65 0 NA
14 hsa-miR-590-3p ABCC9 2.59 0 -2.76 0 miRanda; mirMAP -0.64 0 NA
15 hsa-let-7a-3p ABCD2 1.42 0 -3.08 0 mirMAP -0.67 0 NA
16 hsa-miR-361-5p ABCD2 0.97 0 -3.08 0 miRanda -1.28 0 NA
17 hsa-miR-590-3p ABCD2 2.59 0 -3.08 0 MirTarget; miRanda; mirMAP -0.35 3.0E-5 NA
18 hsa-let-7a-3p ABCD3 1.42 0 0.14 0.52609 MirTarget -0.12 0.02959 NA
19 hsa-miR-590-3p ABHD2 2.59 0 -0.37 0.12248 miRanda; mirMAP -0.15 0.00026 NA
20 hsa-miR-125a-5p ABHD3 0.6 0.01023 0.98 0 PITA; miRanda -0.1 0.01012 NA
21 hsa-miR-590-3p ABI2 2.59 0 -0.65 0 miRanda; mirMAP -0.11 0 NA
22 hsa-let-7a-3p ABI3BP 1.42 0 -4.28 0 miRNATAP -0.98 0 NA
23 hsa-miR-181b-5p ABI3BP 2.49 0 -4.28 0 miRNATAP -0.74 0 NA
24 hsa-miR-590-3p ABI3BP 2.59 0 -4.28 0 miRanda -0.81 0 NA
25 hsa-miR-361-5p ABL1 0.97 0 -1.32 0 miRanda -0.32 0 NA
26 hsa-miR-125a-5p ABL2 0.6 0.01023 -0.32 0.04554 MirTarget; PITA -0.22 0 26766902 MicroRNA 125a 5p modulates human cervical carcinoma proliferation and migration by targeting ABL2; The direct regulation of miR-125a-5p on its target gene ABL proto-oncogene 2 ABL2 in cervical carcinoma was evaluated by quantitative real-time reverse transcription polymerase chain reaction Western blotting and luciferase reporter assays respectively; ABL2 was shown to be directly targeted by miR-125a-5p; In cervical carcinoma ABL2 gene and protein levels were both downregulated by miR-125a-5p
27 hsa-miR-15a-5p ABL2 2.35 0 -0.32 0.04554 MirTarget; miRNATAP -0.16 0 NA
28 hsa-miR-200c-3p ABL2 3.5 0 -0.32 0.04554 MirTarget -0.15 0 NA
29 hsa-miR-361-5p ABL2 0.97 0 -0.32 0.04554 mirMAP -0.15 0.00146 NA
30 hsa-let-7a-3p ABLIM1 1.42 0 -1.72 0 mirMAP -0.15 0.02468 NA
31 hsa-miR-590-3p ABLIM1 2.59 0 -1.72 0 miRanda; mirMAP -0.17 0.0006 NA
32 hsa-miR-361-5p ACACB 0.97 0 -2.93 0 miRanda -0.48 0 NA
33 hsa-miR-590-3p ACADSB 2.59 0 -1 0.00017 MirTarget; miRanda; mirMAP -0.19 5.0E-5 NA
34 hsa-miR-125a-5p ACAT1 0.6 0.01023 -1.05 0 miRanda -0.26 0 NA
35 hsa-miR-590-3p ACAT1 2.59 0 -1.05 0 mirMAP -0.13 0.00058 NA
36 hsa-miR-590-3p ACOT1 2.59 0 -0.69 0.00048 miRanda -0.21 0 NA
37 hsa-miR-590-3p ACOT2 2.59 0 -0.56 0.00263 miRanda -0.17 0 NA
38 hsa-miR-590-3p ACOX2 2.59 0 -3.75 0 miRanda -0.71 0 NA
39 hsa-miR-181b-5p ACSL1 2.49 0 -0 0.993 MirTarget -0.12 0.00517 NA
40 hsa-miR-181b-5p ACSS3 2.49 0 -2.48 1.0E-5 MirTarget -0.25 0.01051 NA
41 hsa-miR-590-3p ACSS3 2.59 0 -2.48 1.0E-5 miRanda -0.58 0 NA
42 hsa-miR-590-3p ACTB 2.59 0 -0.54 0.00046 miRanda -0.1 0.00016 NA
43 hsa-miR-125a-5p ACTBL2 0.6 0.01023 1.68 0.00368 miRanda -0.67 0 NA
44 hsa-miR-200c-3p ACTC1 3.5 0 -7.19 0 MirTarget -1.34 0 NA
45 hsa-miR-361-5p ACTC1 0.97 0 -7.19 0 miRanda; miRNATAP -3.21 0 NA
46 hsa-miR-590-3p ACTC1 2.59 0 -7.19 0 miRanda -1.76 0 NA
47 hsa-miR-125a-5p ACTG2 0.6 0.01023 -5.39 0 miRanda -0.51 0.00044 NA
48 hsa-miR-590-3p ACTG2 2.59 0 -5.39 0 miRanda -1.27 0 NA
49 hsa-miR-590-3p ACTN1 2.59 0 -1.05 0.00011 miRanda; miRNATAP -0.33 0 NA
50 hsa-miR-361-5p ACTN4 0.97 0 -0.06 0.65476 miRanda -0.18 1.0E-5 NA
51 hsa-miR-590-3p ACVR1 2.59 0 -0.44 0.01143 miRanda -0.2 0 NA
52 hsa-miR-361-5p ADAM12 0.97 0 0.88 0.05623 miRanda -0.82 0 NA
53 hsa-miR-590-3p ADAM12 2.59 0 0.88 0.05623 mirMAP -0.23 0.00464 NA
54 hsa-miR-125a-5p ADAM19 0.6 0.01023 -1.06 0.01895 mirMAP -0.65 0 NA
55 hsa-miR-361-5p ADAM19 0.97 0 -1.06 0.01895 miRanda -1.17 0 NA
56 hsa-miR-590-3p ADAM19 2.59 0 -1.06 0.01895 miRanda -0.23 0.00353 NA
57 hsa-miR-361-5p ADAM28 0.97 0 -0.73 0.15943 mirMAP -0.49 0.00113 NA
58 hsa-miR-590-3p ADAM32 2.59 0 -0.49 0.23688 miRanda -0.16 0.0295 NA
59 hsa-miR-590-3p ADAM33 2.59 0 -4.48 0 miRanda -0.8 0 NA
60 hsa-miR-590-3p ADAM9 2.59 0 -0.2 0.40665 miRanda; mirMAP -0.17 4.0E-5 NA
61 hsa-miR-181b-5p ADAMTS1 2.49 0 -3.81 0 miRNATAP -0.53 0 NA
62 hsa-miR-590-3p ADAMTS1 2.59 0 -3.81 0 miRanda -0.59 0 NA
63 hsa-miR-125a-5p ADAMTS14 0.6 0.01023 0.61 0.12479 miRanda; mirMAP -0.23 0.00478 NA
64 hsa-miR-590-3p ADAMTS14 2.59 0 0.61 0.12479 miRanda -0.14 0.03948 NA
65 hsa-miR-125a-5p ADAMTS15 0.6 0.01023 -2.81 0 mirMAP -0.81 0 NA
66 hsa-miR-590-3p ADAMTS16 2.59 0 -1.54 0.01905 miRanda; mirMAP -0.77 0 NA
67 hsa-miR-590-3p ADAMTS17 2.59 0 -1.24 0.00463 miRanda -0.2 0.01117 NA
68 hsa-miR-15a-5p ADAMTS18 2.35 0 -0.74 0.14599 miRNATAP -0.48 0 NA
69 hsa-miR-181b-5p ADAMTS18 2.49 0 -0.74 0.14599 miRNATAP -0.17 0.04646 NA
70 hsa-miR-590-3p ADAMTS18 2.59 0 -0.74 0.14599 PITA; miRanda; miRNATAP -0.43 0 NA
71 hsa-miR-15a-5p ADAMTS3 2.35 0 -1.18 0.00448 miRNATAP -0.53 0 NA
72 hsa-miR-200c-3p ADAMTS3 3.5 0 -1.18 0.00448 miRNATAP -0.41 0 NA
73 hsa-miR-590-3p ADAMTS3 2.59 0 -1.18 0.00448 miRanda; mirMAP -0.21 0.00422 NA
74 hsa-let-7a-3p ADAMTS5 1.42 0 -2.16 0 mirMAP -0.34 1.0E-5 NA
75 hsa-miR-15a-5p ADAMTS5 2.35 0 -2.16 0 miRNATAP -0.43 0 NA
76 hsa-miR-181b-5p ADAMTS5 2.49 0 -2.16 0 mirMAP; miRNATAP -0.25 1.0E-5 NA
77 hsa-miR-361-5p ADAMTS5 0.97 0 -2.16 0 PITA; miRanda -0.64 0 NA
78 hsa-miR-590-3p ADAMTS5 2.59 0 -2.16 0 PITA; miRanda; miRNATAP -0.4 0 NA
79 hsa-miR-181b-5p ADAMTS6 2.49 0 -0.88 0.01914 miRNATAP -0.13 0.03705 NA
80 hsa-miR-590-3p ADAMTS6 2.59 0 -0.88 0.01914 miRanda -0.27 6.0E-5 NA
81 hsa-miR-590-3p ADAMTS8 2.59 0 -4.33 0 miRanda -0.94 0 NA
82 hsa-miR-590-3p ADAMTS9 2.59 0 -1.79 0 miRanda -0.36 0 NA
83 hsa-miR-181b-5p ADAMTSL1 2.49 0 -2.52 0 miRNATAP -0.35 1.0E-5 NA
84 hsa-miR-590-3p ADAMTSL1 2.59 0 -2.52 0 miRanda; mirMAP -0.49 0 NA
85 hsa-let-7a-3p ADAMTSL3 1.42 0 -5.11 0 MirTarget -1.04 0 NA
86 hsa-miR-15a-5p ADAMTSL3 2.35 0 -5.11 0 MirTarget -1.2 0 NA
87 hsa-miR-590-3p ADAMTSL3 2.59 0 -5.11 0 miRanda -0.92 0 NA
88 hsa-miR-590-3p ADAMTSL5 2.59 0 -0.41 0.32739 miRanda -0.15 0.03422 NA
89 hsa-miR-125a-5p ADARB1 0.6 0.01023 -1.93 0 mirMAP -0.26 7.0E-5 NA
90 hsa-miR-181b-5p ADARB1 2.49 0 -1.93 0 MirTarget; miRNATAP -0.36 0 NA
91 hsa-miR-590-3p ADARB1 2.59 0 -1.93 0 miRanda; mirMAP -0.44 0 NA
92 hsa-miR-200c-3p ADCY2 3.5 0 -3.87 0 MirTarget; miRNATAP -0.44 0 NA
93 hsa-miR-361-5p ADCY2 0.97 0 -3.87 0 MirTarget; PITA; miRanda; miRNATAP -1.04 0 NA
94 hsa-miR-590-3p ADCY2 2.59 0 -3.87 0 mirMAP -0.75 0 NA
95 hsa-miR-15a-5p ADCY5 2.35 0 -5.17 0 MirTarget; miRNATAP -1.03 0 NA
96 hsa-miR-125a-5p ADCY9 0.6 0.01023 -1.5 0 mirMAP -0.32 0 NA
97 hsa-miR-181b-5p ADCY9 2.49 0 -1.5 0 miRNATAP -0.24 0 24269684 miR 181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 AC9 in cervical cancer cells; Phenotypic experiments indicated that miR-181b and AC9 exerted opposite effects on cell proliferation and apoptosis
98 hsa-miR-361-5p ADCY9 0.97 0 -1.5 0 miRanda -0.65 0 NA
99 hsa-miR-590-3p ADCY9 2.59 0 -1.5 0 miRanda -0.26 0 NA
100 hsa-let-7a-3p ADCYAP1 1.42 0 -3.51 0 miRNATAP -0.66 0 NA
101 hsa-miR-361-5p ADCYAP1 0.97 0 -3.51 0 miRanda -0.98 0 NA
102 hsa-miR-590-3p ADCYAP1 2.59 0 -3.51 0 MirTarget; PITA; miRanda; miRNATAP -0.71 0 NA
103 hsa-miR-590-3p ADD1 2.59 0 -0.81 0 MirTarget; PITA; miRanda; miRNATAP -0.14 0 NA
104 hsa-miR-125a-5p ADD2 0.6 0.01023 -0.72 0.25015 MirTarget; miRanda -0.88 0 NA
105 hsa-let-7a-3p ADD3 1.42 0 -0.66 0.00185 mirMAP; miRNATAP -0.14 0.00449 NA
106 hsa-miR-590-3p ADH1A 2.59 0 -4.53 0 miRanda -0.6 0 NA
107 hsa-miR-590-3p ADH1B 2.59 0 -7.89 0 miRanda; mirMAP -1.26 0 NA
108 hsa-miR-590-3p ADH1C 2.59 0 -3.38 7.0E-5 miRanda -0.46 0.00247 NA
109 hsa-miR-590-3p ADIPOQ 2.59 0 -5.02 0 PITA; miRanda; mirMAP -1.12 0 NA
110 hsa-miR-125a-5p ADM2 0.6 0.01023 2.23 0 mirMAP -0.21 0.0146 NA
111 hsa-miR-361-5p ADORA1 0.97 0 0.39 0.31104 miRanda -0.57 0 NA
112 hsa-miR-125a-5p ADPRH 0.6 0.01023 -0.71 0.00334 miRanda -0.21 3.0E-5 NA
113 hsa-miR-361-5p ADRA2A 0.97 0 -2.58 0 miRanda -0.88 0 NA
114 hsa-miR-15a-5p ADRB2 2.35 0 -1.96 1.0E-5 MirTarget -0.26 0.00282 NA
115 hsa-miR-125a-5p ADRB3 0.6 0.01023 -5.02 0 miRanda -0.38 0.00257 NA
116 hsa-miR-125a-5p AEN 0.6 0.01023 -0.36 0.01541 miRanda -0.12 0.00013 NA
117 hsa-miR-590-3p AFAP1 2.59 0 -0.98 0.00012 PITA; miRanda; miRNATAP -0.22 0 NA
118 hsa-miR-125a-5p AFAP1L2 0.6 0.01023 0.06 0.85809 miRanda -0.14 0.03234 NA
119 hsa-miR-181b-5p AFF1 2.49 0 -0.53 0.00163 mirMAP; miRNATAP -0.11 0.00021 NA
120 hsa-let-7a-3p AFF2 1.42 0 -1.73 0.00201 mirMAP -0.29 0.02983 NA
121 hsa-miR-590-3p AFF2 2.59 0 -1.73 0.00201 PITA; miRanda; mirMAP; miRNATAP -0.25 0.01122 NA
122 hsa-let-7a-3p AFF3 1.42 0 -5 0 MirTarget -1.07 0 NA
123 hsa-miR-200c-3p AFF3 3.5 0 -5 0 MirTarget; miRNATAP -0.59 0 NA
124 hsa-miR-590-3p AFF3 2.59 0 -5 0 PITA; miRanda; mirMAP; miRNATAP -0.79 0 NA
125 hsa-miR-15a-5p AFF4 2.35 0 -0.82 0 MirTarget; miRNATAP -0.13 2.0E-5 NA
126 hsa-miR-181b-5p AFF4 2.49 0 -0.82 0 mirMAP; miRNATAP -0.12 0 NA
127 hsa-miR-361-5p AFF4 0.97 0 -0.82 0 miRanda -0.1 0.02408 NA
128 hsa-miR-590-3p AFF4 2.59 0 -0.82 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.11 2.0E-5 NA
129 hsa-miR-181b-5p AGFG2 2.49 0 -0.51 0.00539 mirMAP -0.11 0.00068 NA
130 hsa-miR-590-3p AGL 2.59 0 -0.67 6.0E-5 PITA; miRanda; mirMAP; miRNATAP -0.12 6.0E-5 NA
131 hsa-miR-125a-5p AGPAT4 0.6 0.01023 -0.79 0.01174 miRanda -0.26 9.0E-5 NA
132 hsa-miR-15a-5p AGPAT4 2.35 0 -0.79 0.01174 mirMAP -0.18 0.0035 NA
133 hsa-miR-361-5p AGPS 0.97 0 -0.1 0.48101 miRanda; miRNATAP -0.13 0.00105 NA
134 hsa-miR-590-3p AGT 2.59 0 -1.62 0.00168 miRanda -0.31 0.0007 NA
135 hsa-miR-590-3p AGTR1 2.59 0 -4.49 0 miRanda -1.09 0 NA
136 hsa-miR-125a-5p AGTRAP 0.6 0.01023 0.96 0 miRNAWalker2 validate; miRanda -0.1 0.01113 NA
137 hsa-miR-361-5p AHNAK 0.97 0 -1.66 0 miRanda -0.55 0 NA
138 hsa-miR-590-3p AHNAK 2.59 0 -1.66 0 miRanda -0.32 0 NA
139 hsa-miR-361-5p AIDA 0.97 0 -0.31 0.01307 miRanda -0.22 0 NA
140 hsa-miR-361-5p AJAP1 0.97 0 -1.65 0.0004 miRanda -0.38 0.0057 NA
141 hsa-miR-590-3p AK5 2.59 0 -1.18 0.03248 miRanda; mirMAP -0.21 0.02614 NA
142 hsa-let-7a-3p AKAP11 1.42 0 -0.8 0 mirMAP -0.16 4.0E-5 NA
143 hsa-miR-125a-5p AKAP11 0.6 0.01023 -0.8 0 miRanda -0.1 0.00318 NA
144 hsa-miR-15a-5p AKAP11 2.35 0 -0.8 0 MirTarget; miRNATAP -0.13 4.0E-5 NA
145 hsa-miR-361-5p AKAP11 0.97 0 -0.8 0 mirMAP -0.16 0.00083 NA
146 hsa-miR-590-3p AKAP11 2.59 0 -0.8 0 MirTarget; miRanda; miRNATAP -0.17 0 NA
147 hsa-let-7a-3p AKAP12 1.42 0 -2.95 0 miRNATAP -0.59 0 NA
148 hsa-miR-361-5p AKAP12 0.97 0 -2.95 0 miRanda -0.63 0 NA
149 hsa-miR-590-3p AKAP12 2.59 0 -2.95 0 miRanda; mirMAP -0.41 0 NA
150 hsa-miR-125a-5p AKAP13 0.6 0.01023 -1.15 0 miRanda -0.18 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 471 1672 1.87e-46 8.701e-43
2 REGULATION OF CELL DIFFERENTIATION 427 1492 9.149e-44 2.129e-40
3 NEUROGENESIS 403 1402 1.088e-41 1.688e-38
4 BIOLOGICAL ADHESION 320 1032 5.659e-40 6.583e-37
5 CARDIOVASCULAR SYSTEM DEVELOPMENT 262 788 2.027e-38 1.572e-35
6 CIRCULATORY SYSTEM DEVELOPMENT 262 788 2.027e-38 1.572e-35
7 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 445 1656 4.371e-38 2.905e-35
8 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 313 1021 5.258e-38 3.058e-35
9 REGULATION OF CELLULAR COMPONENT MOVEMENT 256 771 1.996e-37 1.032e-34
10 CELL DEVELOPMENT 395 1426 8.544e-37 3.975e-34
11 RESPONSE TO ENDOGENOUS STIMULUS 398 1450 4.116e-36 1.741e-33
12 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 332 1142 3.313e-35 1.285e-32
13 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 473 1848 8.648e-35 3.095e-32
14 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 383 1395 9.912e-35 3.294e-32
15 REGULATION OF CELL DEVELOPMENT 264 836 2.108e-34 6.538e-32
16 TISSUE DEVELOPMENT 406 1518 4.16e-34 1.21e-31
17 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 299 1008 2.187e-33 5.986e-31
18 VASCULATURE DEVELOPMENT 173 469 1.192e-31 3.082e-29
19 POSITIVE REGULATION OF MOLECULAR FUNCTION 452 1791 1.263e-31 3.093e-29
20 REGULATION OF CELL PROLIFERATION 393 1496 3.46e-31 8.049e-29
21 POSITIVE REGULATION OF RESPONSE TO STIMULUS 475 1929 1.408e-30 3.12e-28
22 NEGATIVE REGULATION OF CELL COMMUNICATION 328 1192 7.68e-30 1.624e-27
23 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 361 1360 1.576e-29 3.188e-27
24 REGULATION OF PHOSPHORUS METABOLIC PROCESS 409 1618 1.177e-28 2.282e-26
25 POSITIVE REGULATION OF CELL COMMUNICATION 391 1532 2.966e-28 5.519e-26
26 POSITIVE REGULATION OF CELL DIFFERENTIATION 246 823 4.905e-28 8.779e-26
27 INTRACELLULAR SIGNAL TRANSDUCTION 396 1572 2.146e-27 3.699e-25
28 LOCOMOTION 304 1114 5.501e-27 9.142e-25
29 RESPONSE TO OXYGEN CONTAINING COMPOUND 357 1381 7.469e-27 1.198e-24
30 BLOOD VESSEL MORPHOGENESIS 138 364 8.226e-27 1.276e-24
31 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 227 750 9.808e-27 1.472e-24
32 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 335 1275 1.611e-26 2.343e-24
33 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 237 799 1.668e-26 2.352e-24
34 REGULATION OF NEURON DIFFERENTIATION 182 554 3.858e-26 5.145e-24
35 NEURON DIFFERENTIATION 252 874 3.87e-26 5.145e-24
36 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 273 983 1.642e-25 2.123e-23
37 REGULATION OF PROTEIN MODIFICATION PROCESS 413 1710 1.236e-24 1.554e-22
38 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 208 689 2.13e-24 2.608e-22
39 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 231 801 5.091e-24 6.074e-22
40 MUSCLE STRUCTURE DEVELOPMENT 149 432 6.041e-24 7.027e-22
41 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 166 513 3.908e-23 4.435e-21
42 CENTRAL NERVOUS SYSTEM DEVELOPMENT 243 872 5.585e-23 6.187e-21
43 POSITIVE REGULATION OF CATALYTIC ACTIVITY 370 1518 8.912e-23 9.492e-21
44 ORGAN MORPHOGENESIS 236 841 8.976e-23 9.492e-21
45 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 258 957 3.821e-22 3.951e-20
46 HEART DEVELOPMENT 153 466 4.159e-22 4.207e-20
47 REGULATION OF CELL MORPHOGENESIS 172 552 6.08e-22 6.019e-20
48 SKELETAL SYSTEM DEVELOPMENT 150 455 6.852e-22 6.642e-20
49 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 273 1036 7.646e-22 7.115e-20
50 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 273 1036 7.646e-22 7.115e-20
51 REGULATION OF MAPK CASCADE 194 660 2.48e-21 2.262e-19
52 REGULATION OF CELL PROJECTION ORGANIZATION 171 558 5.65e-21 5.056e-19
53 CELL MOTILITY 229 835 9.771e-21 8.267e-19
54 LOCALIZATION OF CELL 229 835 9.771e-21 8.267e-19
55 RESPONSE TO GROWTH FACTOR 152 475 9.492e-21 8.267e-19
56 ANGIOGENESIS 109 293 1.084e-20 9.01e-19
57 NEURON DEVELOPMENT 198 687 1.143e-20 9.33e-19
58 CELLULAR COMPONENT MORPHOGENESIS 242 900 1.193e-20 9.57e-19
59 REGULATION OF HYDROLASE ACTIVITY 326 1327 1.214e-20 9.575e-19
60 POSITIVE REGULATION OF LOCOMOTION 139 420 1.526e-20 1.184e-18
61 HEAD DEVELOPMENT 202 709 1.97e-20 1.478e-18
62 REGULATION OF NEURON PROJECTION DEVELOPMENT 136 408 1.944e-20 1.478e-18
63 EXTRACELLULAR STRUCTURE ORGANIZATION 111 304 2.589e-20 1.912e-18
64 REGULATION OF TRANSPORT 414 1804 3.096e-20 2.251e-18
65 RESPONSE TO WOUNDING 170 563 4.009e-20 2.87e-18
66 RESPONSE TO NITROGEN COMPOUND 232 859 4.361e-20 2.984e-18
67 REGULATION OF KINASE ACTIVITY 215 776 4.335e-20 2.984e-18
68 NEURON PROJECTION DEVELOPMENT 166 545 4.281e-20 2.984e-18
69 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 165 541 4.809e-20 3.196e-18
70 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 165 541 4.809e-20 3.196e-18
71 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 235 876 6.171e-20 4.044e-18
72 REGULATION OF GTPASE ACTIVITY 193 673 6.603e-20 4.267e-18
73 REGULATION OF SYSTEM PROCESS 157 507 7.846e-20 5.001e-18
74 POSITIVE REGULATION OF GENE EXPRESSION 398 1733 1.668e-19 1.049e-17
75 POSITIVE REGULATION OF CELL DEVELOPMENT 148 472 2.575e-19 1.598e-17
76 REGULATION OF CELL DEATH 348 1472 3.968e-19 2.429e-17
77 BEHAVIOR 157 516 5.117e-19 3.092e-17
78 POSITIVE REGULATION OF HYDROLASE ACTIVITY 238 905 5.241e-19 3.127e-17
79 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 405 1784 6.41e-19 3.775e-17
80 CELL ACTIVATION 168 568 6.625e-19 3.853e-17
81 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 116 337 7.8e-19 4.481e-17
82 RESPONSE TO HORMONE 235 893 8.146e-19 4.622e-17
83 CELLULAR RESPONSE TO NITROGEN COMPOUND 154 505 8.89e-19 4.984e-17
84 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 349 1492 2.064e-18 1.143e-16
85 POSITIVE REGULATION OF MAPK CASCADE 145 470 3.031e-18 1.659e-16
86 RESPONSE TO LIPID 232 888 3.541e-18 1.916e-16
87 NEGATIVE REGULATION OF PHOSPHORYLATION 134 422 4.078e-18 2.181e-16
88 TUBE DEVELOPMENT 161 552 1.559e-17 8.241e-16
89 CONNECTIVE TISSUE DEVELOPMENT 78 194 1.953e-17 1.021e-15
90 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 99 278 2.101e-17 1.086e-15
91 CELL CELL ADHESION 172 608 3.199e-17 1.636e-15
92 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 277 1135 3.318e-17 1.678e-15
93 POSITIVE REGULATION OF CELL PROLIFERATION 214 814 3.674e-17 1.838e-15
94 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 135 437 3.992e-17 1.976e-15
95 NEGATIVE REGULATION OF CELL PROLIFERATION 179 643 4.094e-17 2.005e-15
96 RESPONSE TO ABIOTIC STIMULUS 255 1024 4.868e-17 2.36e-15
97 CELL PROJECTION ORGANIZATION 231 902 5.288e-17 2.537e-15
98 REGULATION OF ION TRANSPORT 168 592 5.469e-17 2.597e-15
99 PROTEIN PHOSPHORYLATION 239 944 6.349e-17 2.984e-15
100 RESPONSE TO EXTERNAL STIMULUS 402 1821 1.236e-16 5.751e-15
101 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 278 1152 1.382e-16 6.366e-15
102 MUSCLE ORGAN DEVELOPMENT 97 277 1.584e-16 7.228e-15
103 TISSUE MORPHOGENESIS 154 533 2.016e-16 9.106e-15
104 RESPONSE TO ORGANIC CYCLIC COMPOUND 232 917 2.045e-16 9.15e-15
105 WOUND HEALING 140 470 3.118e-16 1.382e-14
106 SINGLE ORGANISM BEHAVIOR 121 384 3.359e-16 1.474e-14
107 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 397 1805 3.696e-16 1.607e-14
108 NEGATIVE REGULATION OF CELL DIFFERENTIATION 169 609 4.417e-16 1.903e-14
109 EPITHELIUM DEVELOPMENT 236 945 5.527e-16 2.359e-14
110 ACTIN FILAMENT BASED PROCESS 135 450 5.68e-16 2.403e-14
111 REGULATION OF METAL ION TRANSPORT 107 325 6.214e-16 2.605e-14
112 REGULATION OF BLOOD CIRCULATION 100 295 6.432e-16 2.672e-14
113 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 132 437 6.625e-16 2.728e-14
114 REGULATION OF VASCULATURE DEVELOPMENT 85 233 7.55e-16 3.081e-14
115 REGULATION OF CELL ADHESION 172 629 1.083e-15 4.38e-14
116 CELLULAR RESPONSE TO HORMONE STIMULUS 156 552 1.098e-15 4.406e-14
117 NEURON PROJECTION MORPHOGENESIS 123 402 2.275e-15 9.048e-14
118 CIRCULATORY SYSTEM PROCESS 115 366 2.305e-15 9.089e-14
119 POSITIVE REGULATION OF NEURON DIFFERENTIATION 101 306 3.382e-15 1.323e-13
120 REGULATION OF GROWTH 171 633 4.44e-15 1.721e-13
121 REGULATION OF TRANSFERASE ACTIVITY 233 946 4.518e-15 1.737e-13
122 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 82 229 8.26e-15 3.132e-13
123 TAXIS 135 464 8.279e-15 3.132e-13
124 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 114 368 9.293e-15 3.487e-13
125 MUSCLE SYSTEM PROCESS 94 282 1.553e-14 5.78e-13
126 POSITIVE REGULATION OF KINASE ACTIVITY 138 482 1.676e-14 6.191e-13
127 POSITIVE REGULATION OF TRANSPORT 229 936 1.712e-14 6.273e-13
128 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 141 498 2.289e-14 8.323e-13
129 EMBRYO DEVELOPMENT 220 894 3.045e-14 1.098e-12
130 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 241 1004 3.246e-14 1.162e-12
131 REGULATION OF MEMBRANE POTENTIAL 107 343 3.703e-14 1.315e-12
132 SINGLE ORGANISM CELL ADHESION 132 459 4.36e-14 1.537e-12
133 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 189 740 5.607e-14 1.962e-12
134 MUSCLE TISSUE DEVELOPMENT 91 275 6.644e-14 2.307e-12
135 BONE DEVELOPMENT 62 156 7.028e-14 2.422e-12
136 RESPONSE TO OXYGEN LEVELS 99 311 8.298e-14 2.839e-12
137 REGULATION OF HEART CONTRACTION 78 221 9.014e-14 3.061e-12
138 FOREBRAIN DEVELOPMENT 109 357 1.05e-13 3.539e-12
139 CARTILAGE DEVELOPMENT 59 147 1.693e-13 5.667e-12
140 MUSCLE CELL DIFFERENTIATION 81 237 2.235e-13 7.429e-12
141 REGULATION OF DEVELOPMENTAL GROWTH 93 289 2.299e-13 7.585e-12
142 IMMUNE SYSTEM PROCESS 415 1984 2.906e-13 9.523e-12
143 REGULATION OF CELL SUBSTRATE ADHESION 65 173 3.904e-13 1.27e-11
144 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 56 138 4.034e-13 1.304e-11
145 STEM CELL DIFFERENTIATION 69 190 5.037e-13 1.616e-11
146 REGULATION OF CELLULAR COMPONENT BIOGENESIS 191 767 5.192e-13 1.655e-11
147 SENSORY ORGAN DEVELOPMENT 136 493 5.656e-13 1.79e-11
148 IMMUNE SYSTEM DEVELOPMENT 154 582 6.551e-13 2.06e-11
149 NEGATIVE REGULATION OF LOCOMOTION 86 263 6.796e-13 2.122e-11
150 EMBRYONIC MORPHOGENESIS 145 539 8.028e-13 2.49e-11
151 CELLULAR RESPONSE TO LIPID 128 457 8.533e-13 2.629e-11
152 GROWTH 118 410 9.282e-13 2.841e-11
153 CELL CELL SIGNALING 190 767 9.985e-13 3.037e-11
154 DEVELOPMENTAL GROWTH 101 333 1.32e-12 3.988e-11
155 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 130 470 1.505e-12 4.518e-11
156 MESENCHYME DEVELOPMENT 68 190 1.635e-12 4.876e-11
157 REGULATION OF EPITHELIAL CELL MIGRATION 62 166 1.834e-12 5.434e-11
158 REGULATION OF EPITHELIAL CELL PROLIFERATION 90 285 1.845e-12 5.434e-11
159 LEUKOCYTE ACTIVATION 118 414 1.895e-12 5.545e-11
160 UROGENITAL SYSTEM DEVELOPMENT 93 299 2.094e-12 6.089e-11
161 NEGATIVE REGULATION OF CELL DEATH 209 872 2.129e-12 6.154e-11
162 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 159 616 2.423e-12 6.961e-11
163 TUBE MORPHOGENESIS 98 323 2.78e-12 7.935e-11
164 REGULATION OF RESPONSE TO STRESS 318 1468 3.562e-12 1.011e-10
165 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 218 926 4.467e-12 1.26e-10
166 NEGATIVE REGULATION OF GENE EXPRESSION 322 1493 4.503e-12 1.262e-10
167 PHOSPHORYLATION 274 1228 4.597e-12 1.281e-10
168 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 93 303 4.854e-12 1.344e-10
169 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 71 207 5.505e-12 1.516e-10
170 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 407 1977 5.624e-12 1.539e-10
171 REGULATION OF RESPONSE TO WOUNDING 116 413 8.298e-12 2.258e-10
172 REGULATION OF HOMEOSTATIC PROCESS 123 447 8.82e-12 2.386e-10
173 MORPHOGENESIS OF AN EPITHELIUM 113 400 1.038e-11 2.791e-10
174 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 76 232 1.327e-11 3.549e-10
175 SYNAPSE ORGANIZATION 55 145 1.591e-11 4.231e-10
176 REGULATION OF MAP KINASE ACTIVITY 95 319 1.923e-11 5.084e-10
177 REGULATION OF BODY FLUID LEVELS 134 506 1.985e-11 5.219e-10
178 MESENCHYMAL CELL DIFFERENTIATION 52 134 2.077e-11 5.428e-10
179 REGULATION OF CALCIUM ION TRANSPORT 70 209 2.704e-11 7.029e-10
180 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 64 184 3.045e-11 7.871e-10
181 NEGATIVE REGULATION OF CELL DEVELOPMENT 91 303 3.075e-11 7.904e-10
182 REGULATION OF CELLULAR LOCALIZATION 279 1277 3.319e-11 8.486e-10
183 POSITIVE REGULATION OF ION TRANSPORT 76 236 3.372e-11 8.528e-10
184 POSITIVE REGULATION OF CELL DEATH 153 605 3.368e-11 8.528e-10
185 SECOND MESSENGER MEDIATED SIGNALING 58 160 3.849e-11 9.681e-10
186 REGULATION OF TRANSPORTER ACTIVITY 67 198 4.285e-11 1.072e-09
187 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 65 190 4.872e-11 1.212e-09
188 REGULATION OF MUSCLE SYSTEM PROCESS 66 195 5.903e-11 1.461e-09
189 REGULATION OF TRANSMEMBRANE TRANSPORT 116 426 7.057e-11 1.737e-09
190 REGULATION OF ACTIN FILAMENT BASED PROCESS 92 312 7.2e-11 1.763e-09
191 MORPHOGENESIS OF A BRANCHING STRUCTURE 59 167 8.698e-11 2.119e-09
192 RESPONSE TO STEROID HORMONE 130 497 9.718e-11 2.351e-09
193 RESPIRATORY SYSTEM DEVELOPMENT 66 197 9.75e-11 2.351e-09
194 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 74 232 1.006e-10 2.414e-09
195 CYTOSKELETON ORGANIZATION 196 838 1.028e-10 2.442e-09
196 LYMPHOCYTE ACTIVATION 98 342 1.029e-10 2.442e-09
197 NEGATIVE REGULATION OF TRANSPORT 122 458 1.062e-10 2.509e-09
198 TELENCEPHALON DEVELOPMENT 73 228 1.106e-10 2.598e-09
199 COGNITION 78 251 1.299e-10 3.038e-09
200 LEUKOCYTE DIFFERENTIATION 87 292 1.309e-10 3.046e-09
201 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 53 144 1.378e-10 3.19e-09
202 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 123 465 1.447e-10 3.333e-09
203 CHEMICAL HOMEOSTASIS 202 874 1.576e-10 3.611e-09
204 HEART MORPHOGENESIS 69 212 1.583e-10 3.611e-09
205 CELL PART MORPHOGENESIS 156 633 1.712e-10 3.886e-09
206 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 68 208 1.724e-10 3.894e-09
207 REGULATION OF OSSIFICATION 61 178 1.752e-10 3.939e-09
208 HOMEOSTATIC PROCESS 286 1337 2.03e-10 4.52e-09
209 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 318 1517 2.022e-10 4.52e-09
210 RESPONSE TO PEPTIDE 110 404 2.2e-10 4.875e-09
211 CELLULAR RESPONSE TO ACID CHEMICAL 60 175 2.413e-10 5.322e-09
212 REGULATION OF ION HOMEOSTASIS 66 201 2.581e-10 5.665e-09
213 EMBRYONIC ORGAN DEVELOPMENT 110 406 3.017e-10 6.59e-09
214 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 240 1087 3.125e-10 6.794e-09
215 HEMOSTASIS 90 311 3.393e-10 7.342e-09
216 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 79 262 4.925e-10 1.061e-08
217 RESPONSE TO INORGANIC SUBSTANCE 124 479 5.325e-10 1.142e-08
218 NEGATIVE REGULATION OF GROWTH 73 236 6.346e-10 1.354e-08
219 NEGATIVE REGULATION OF KINASE ACTIVITY 76 250 6.917e-10 1.47e-08
220 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 30 62 7.017e-10 1.484e-08
221 FAT CELL DIFFERENTIATION 42 106 8.103e-10 1.706e-08
222 PLATELET ACTIVATION 51 142 8.313e-10 1.742e-08
223 NEURON MIGRATION 43 110 8.446e-10 1.762e-08
224 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 150 616 9.486e-10 1.97e-08
225 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 41 103 1.089e-09 2.252e-08
226 REGULATION OF CARTILAGE DEVELOPMENT 30 63 1.146e-09 2.359e-08
227 STRIATED MUSCLE CELL DIFFERENTIATION 58 173 1.267e-09 2.598e-08
228 RESPONSE TO CYTOKINE 168 714 1.457e-09 2.974e-08
229 CARDIAC MUSCLE TISSUE DEVELOPMENT 50 140 1.515e-09 3.079e-08
230 CELLULAR RESPONSE TO PEPTIDE 80 274 2.042e-09 4.131e-08
231 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 107 404 2.103e-09 4.236e-08
232 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 48 133 2.146e-09 4.304e-08
233 MUSCLE CONTRACTION 71 233 2.225e-09 4.443e-08
234 REGULATION OF PROTEIN LOCALIZATION 211 950 2.329e-09 4.631e-08
235 REGULATION OF CELL GROWTH 104 391 2.748e-09 5.44e-08
236 REGULATION OF SECRETION 164 699 2.854e-09 5.627e-08
237 NEGATIVE REGULATION OF MOLECULAR FUNCTION 234 1079 2.899e-09 5.692e-08
238 CELL SUBSTRATE ADHESION 55 164 3.317e-09 6.484e-08
239 ACTIVATION OF PROTEIN KINASE ACTIVITY 80 279 5.081e-09 9.893e-08
240 OSSIFICATION 74 251 5.118e-09 9.923e-08
241 SKELETAL SYSTEM MORPHOGENESIS 63 201 5.218e-09 1.007e-07
242 CARDIOCYTE DIFFERENTIATION 38 96 5.276e-09 1.015e-07
243 REGULATION OF ORGAN MORPHOGENESIS 72 242 5.363e-09 1.027e-07
244 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 39 100 5.489e-09 1.047e-07
245 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 40 104 5.637e-09 1.071e-07
246 RESPONSE TO ALCOHOL 97 362 6.214e-09 1.175e-07
247 REGULATION OF ANATOMICAL STRUCTURE SIZE 119 472 6.336e-09 1.194e-07
248 CELL DEATH 218 1001 7.2e-09 1.351e-07
249 MODULATION OF SYNAPTIC TRANSMISSION 84 301 8.551e-09 1.598e-07
250 REGULATION OF PHOSPHOLIPASE ACTIVITY 29 64 9.047e-09 1.684e-07
251 ENDOTHELIUM DEVELOPMENT 36 90 9.529e-09 1.766e-07
252 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 88 321 9.681e-09 1.788e-07
253 EYE DEVELOPMENT 89 326 9.93e-09 1.826e-07
254 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 60 191 1.091e-08 1.99e-07
255 REGULATION OF CELL JUNCTION ASSEMBLY 30 68 1.089e-08 1.99e-07
256 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 52 156 1.112e-08 2.021e-07
257 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 51 152 1.197e-08 2.167e-07
258 LEARNING 46 131 1.243e-08 2.242e-07
259 RESPONSE TO MECHANICAL STIMULUS 64 210 1.343e-08 2.413e-07
260 CARDIAC CHAMBER DEVELOPMENT 49 144 1.371e-08 2.453e-07
261 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 162 1.665e-08 2.968e-07
262 REGULATION OF CHEMOTAXIS 57 180 1.829e-08 3.248e-07
263 REGULATION OF IMMUNE SYSTEM PROCESS 287 1403 2.097e-08 3.698e-07
264 DEVELOPMENTAL CELL GROWTH 32 77 2.098e-08 3.698e-07
265 LEUKOCYTE MIGRATION 74 259 2.224e-08 3.905e-07
266 LOCOMOTORY BEHAVIOR 57 181 2.279e-08 3.987e-07
267 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 43 121 2.453e-08 4.275e-07
268 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 30 70 2.468e-08 4.284e-07
269 REGULATION OF RECEPTOR ACTIVITY 42 117 2.542e-08 4.382e-07
270 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 77 274 2.543e-08 4.382e-07
271 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 93 352 2.662e-08 4.571e-07
272 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 26 56 2.826e-08 4.834e-07
273 CALCIUM ION TRANSPORT 66 223 2.868e-08 4.889e-07
274 REGULATION OF BLOOD PRESSURE 54 169 3.048e-08 5.176e-07
275 NEURON PROJECTION GUIDANCE 62 205 3.087e-08 5.224e-07
276 REGULATION OF CHONDROCYTE DIFFERENTIATION 23 46 3.101e-08 5.228e-07
277 SYSTEM PROCESS 352 1785 3.114e-08 5.231e-07
278 RESPONSE TO ACID CHEMICAL 86 319 3.282e-08 5.484e-07
279 REGULATION OF INTRACELLULAR TRANSPORT 145 621 3.288e-08 5.484e-07
280 REGULATION OF MUSCLE CELL DIFFERENTIATION 50 152 3.435e-08 5.708e-07
281 CALCIUM MEDIATED SIGNALING 35 90 3.575e-08 5.92e-07
282 CELL GROWTH 46 135 3.589e-08 5.921e-07
283 REGULATION OF PROTEIN SECRETION 100 389 3.614e-08 5.942e-07
284 REGULATION OF CYTOPLASMIC TRANSPORT 118 481 3.803e-08 6.231e-07
285 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 60 197 3.865e-08 6.31e-07
286 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 53 166 4.196e-08 6.827e-07
287 PALLIUM DEVELOPMENT 50 153 4.358e-08 7.04e-07
288 ION HOMEOSTASIS 136 576 4.349e-08 7.04e-07
289 BONE MORPHOGENESIS 32 79 4.374e-08 7.043e-07
290 DIVALENT INORGANIC CATION TRANSPORT 75 268 4.645e-08 7.452e-07
291 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 37 99 5.045e-08 8.068e-07
292 REGULATION OF BINDING 78 283 5.135e-08 8.183e-07
293 MEMBRANE DEPOLARIZATION 27 61 5.384e-08 8.551e-07
294 AMEBOIDAL TYPE CELL MIGRATION 50 154 5.512e-08 8.723e-07
295 RHYTHMIC PROCESS 81 298 5.549e-08 8.752e-07
296 REGULATION OF CELLULAR RESPONSE TO STRESS 157 691 6.013e-08 9.451e-07
297 DIVALENT INORGANIC CATION HOMEOSTASIS 90 343 6.272e-08 9.797e-07
298 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 28 65 6.275e-08 9.797e-07
299 PEPTIDYL TYROSINE MODIFICATION 57 186 6.606e-08 1.028e-06
300 CARDIAC CHAMBER MORPHOGENESIS 38 104 6.74e-08 1.045e-06
301 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 37 100 6.846e-08 1.058e-06
302 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 131 554 7.021e-08 1.082e-06
303 ION TRANSPORT 259 1262 8.082e-08 1.241e-06
304 REGULATION OF ERK1 AND ERK2 CASCADE 68 238 8.144e-08 1.247e-06
305 REGULATION OF MUSCLE CONTRACTION 48 147 8.279e-08 1.263e-06
306 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 155 684 8.722e-08 1.326e-06
307 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 102 406 9.118e-08 1.382e-06
308 POSITIVE REGULATION OF CELL ADHESION 96 376 9.571e-08 1.446e-06
309 SENSORY ORGAN MORPHOGENESIS 68 239 9.717e-08 1.463e-06
310 REGULATION OF ENDOTHELIAL CELL MIGRATION 40 114 1.11e-07 1.666e-06
311 CARDIAC MUSCLE CELL DIFFERENTIATION 30 74 1.12e-07 1.676e-06
312 REPRODUCTIVE SYSTEM DEVELOPMENT 102 408 1.181e-07 1.762e-06
313 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 37 102 1.239e-07 1.842e-06
314 PLASMA MEMBRANE ORGANIZATION 60 203 1.265e-07 1.869e-06
315 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 36 98 1.266e-07 1.869e-06
316 ACTION POTENTIAL 35 94 1.28e-07 1.88e-06
317 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 139 602 1.281e-07 1.88e-06
318 MULTICELLULAR ORGANISMAL SIGNALING 42 123 1.296e-07 1.896e-06
319 REGULATION OF INFLAMMATORY RESPONSE 79 294 1.361e-07 1.985e-06
320 GLOMERULUS DEVELOPMENT 23 49 1.381e-07 2.008e-06
321 RESPONSE TO CORTICOSTEROID 54 176 1.387e-07 2.01e-06
322 MULTI MULTICELLULAR ORGANISM PROCESS 62 213 1.445e-07 2.088e-06
323 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 26 60 1.596e-07 2.299e-06
324 LYMPHOCYTE DIFFERENTIATION 61 209 1.634e-07 2.347e-06
325 REGULATION OF JNK CASCADE 50 159 1.705e-07 2.441e-06
326 REGULATION OF AXONOGENESIS 52 168 1.719e-07 2.454e-06
327 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 24 53 1.733e-07 2.466e-06
328 POSITIVE REGULATION OF HEART GROWTH 16 27 1.837e-07 2.606e-06
329 REGULATED EXOCYTOSIS 64 224 1.935e-07 2.737e-06
330 ORGAN GROWTH 28 68 1.995e-07 2.813e-06
331 REGULATION OF OSTEOBLAST DIFFERENTIATION 39 112 2.004e-07 2.817e-06
332 KIDNEY EPITHELIUM DEVELOPMENT 42 125 2.156e-07 3.021e-06
333 SECRETION BY CELL 116 486 2.34e-07 3.26e-06
334 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 31 80 2.336e-07 3.26e-06
335 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 32 84 2.379e-07 3.305e-06
336 NEGATIVE REGULATION OF CELL GROWTH 52 170 2.61e-07 3.612e-06
337 REGULATION OF STEM CELL DIFFERENTIATION 39 113 2.616e-07 3.612e-06
338 DIGESTIVE SYSTEM DEVELOPMENT 47 148 2.858e-07 3.934e-06
339 CEREBRAL CORTEX DEVELOPMENT 37 105 2.897e-07 3.976e-06
340 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 46 144 3.145e-07 4.303e-06
341 CELLULAR HOMEOSTASIS 151 676 3.234e-07 4.413e-06
342 CELL CHEMOTAXIS 50 162 3.244e-07 4.413e-06
343 REGULATION OF CATABOLIC PROCESS 161 731 3.373e-07 4.576e-06
344 POSITIVE REGULATION OF ENDOCYTOSIS 39 114 3.399e-07 4.597e-06
345 FOREBRAIN CELL MIGRATION 26 62 3.512e-07 4.737e-06
346 EPITHELIAL CELL DIFFERENTIATION 117 495 3.566e-07 4.795e-06
347 MUSCLE HYPERTROPHY 16 28 3.681e-07 4.937e-06
348 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 24 55 4.06e-07 5.429e-06
349 REGULATION OF CELL MATRIX ADHESION 33 90 4.389e-07 5.845e-06
350 NEPHRON DEVELOPMENT 39 115 4.397e-07 5.845e-06
351 MUSCLE CELL DEVELOPMENT 42 128 4.489e-07 5.951e-06
352 VASCULOGENESIS 25 59 4.634e-07 6.125e-06
353 SECRETION 134 588 4.686e-07 6.177e-06
354 COLLAGEN FIBRIL ORGANIZATION 19 38 4.924e-07 6.472e-06
355 REGULATION OF MUSCLE TISSUE DEVELOPMENT 36 103 5.244e-07 6.854e-06
356 REGULATION OF MUSCLE ORGAN DEVELOPMENT 36 103 5.244e-07 6.854e-06
357 APPENDAGE DEVELOPMENT 51 169 5.374e-07 6.985e-06
358 LIMB DEVELOPMENT 51 169 5.374e-07 6.985e-06
359 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 27 67 5.509e-07 7.14e-06
360 AGING 71 264 5.544e-07 7.166e-06
361 VESICLE MEDIATED TRANSPORT 250 1239 5.824e-07 7.507e-06
362 REGULATION OF LIPASE ACTIVITY 31 83 6.084e-07 7.82e-06
363 LEUKOCYTE CELL CELL ADHESION 69 255 6.237e-07 7.995e-06
364 CELLULAR CHEMICAL HOMEOSTASIS 130 570 6.629e-07 8.474e-06
365 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 22 49 6.749e-07 8.584e-06
366 REGULATION OF HEART GROWTH 20 42 6.752e-07 8.584e-06
367 CHONDROCYTE DIFFERENTIATION 25 60 6.804e-07 8.626e-06
368 REGULATION OF WNT SIGNALING PATHWAY 80 310 6.883e-07 8.703e-06
369 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 60 213 7.773e-07 9.802e-06
370 REGULATION OF SYNAPSE ORGANIZATION 38 113 7.816e-07 9.829e-06
371 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 41 126 7.848e-07 9.842e-06
372 REGULATION OF CATION CHANNEL ACTIVITY 32 88 8.091e-07 1.012e-05
373 REGULATION OF PHOSPHOLIPASE C ACTIVITY 19 39 8.238e-07 1.024e-05
374 NEGATIVE CHEMOTAXIS 19 39 8.238e-07 1.024e-05
375 POSITIVE REGULATION OF OSSIFICATION 31 84 8.25e-07 1.024e-05
376 REGULATION OF CALCIUM MEDIATED SIGNALING 29 76 8.279e-07 1.025e-05
377 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 59 209 8.855e-07 1.093e-05
378 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 42 131 9.038e-07 1.113e-05
379 EAR DEVELOPMENT 56 195 9.15e-07 1.123e-05
380 GLAND MORPHOGENESIS 34 97 9.964e-07 1.22e-05
381 RESPONSE TO METAL ION 84 333 1.013e-06 1.238e-05
382 CELL CYCLE ARREST 47 154 1.033e-06 1.255e-05
383 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 47 154 1.033e-06 1.255e-05
384 SYNAPSE ASSEMBLY 27 69 1.1e-06 1.333e-05
385 REGULATION OF ORGAN GROWTH 28 73 1.127e-06 1.363e-05
386 ACTOMYOSIN STRUCTURE ORGANIZATION 29 77 1.137e-06 1.37e-05
387 REGULATION OF FAT CELL DIFFERENTIATION 36 106 1.156e-06 1.39e-05
388 METAL ION TRANSPORT 131 582 1.268e-06 1.52e-05
389 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 16 30 1.298e-06 1.553e-05
390 ACTIN FILAMENT ORGANIZATION 51 174 1.42e-06 1.694e-05
391 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 31 86 1.487e-06 1.768e-05
392 REGULATION OF CARDIAC MUSCLE CONTRACTION 26 66 1.489e-06 1.768e-05
393 REGULATION OF DENDRITE DEVELOPMENT 39 120 1.494e-06 1.769e-05
394 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 27 70 1.534e-06 1.811e-05
395 CELLULAR RESPONSE TO CYTOKINE STIMULUS 135 606 1.578e-06 1.859e-05
396 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 57 203 1.622e-06 1.906e-05
397 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 38 116 1.628e-06 1.908e-05
398 CELL PROLIFERATION 147 672 1.639e-06 1.916e-05
399 MYELOID CELL DIFFERENTIATION 54 189 1.688e-06 1.969e-05
400 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 34 99 1.7e-06 1.973e-05
401 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 34 99 1.7e-06 1.973e-05
402 REGULATION OF VESICLE MEDIATED TRANSPORT 108 462 1.731e-06 2.003e-05
403 CELLULAR RESPONSE TO OXYGEN LEVELS 44 143 1.767e-06 2.04e-05
404 CATION TRANSPORT 169 796 1.958e-06 2.255e-05
405 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 11 16 1.994e-06 2.291e-05
406 DIGESTIVE TRACT MORPHOGENESIS 21 48 2.03e-06 2.327e-05
407 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 38 117 2.062e-06 2.357e-05
408 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 26 67 2.085e-06 2.377e-05
409 ARTERY DEVELOPMENT 28 75 2.121e-06 2.409e-05
410 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 46 153 2.123e-06 2.409e-05
411 REGULATION OF WOUND HEALING 40 126 2.152e-06 2.431e-05
412 LUNG ALVEOLUS DEVELOPMENT 19 41 2.153e-06 2.431e-05
413 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 42 135 2.187e-06 2.464e-05
414 NEGATIVE REGULATION OF SECRETION 56 200 2.193e-06 2.465e-05
415 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 89 365 2.274e-06 2.549e-05
416 RESPONSE TO PURINE CONTAINING COMPOUND 47 158 2.299e-06 2.571e-05
417 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 41 131 2.426e-06 2.705e-05
418 EMBRYONIC ORGAN MORPHOGENESIS 72 279 2.43e-06 2.705e-05
419 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 36 109 2.441e-06 2.711e-05
420 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 32 92 2.485e-06 2.753e-05
421 EPITHELIAL TO MESENCHYMAL TRANSITION 23 56 2.544e-06 2.805e-05
422 OUTFLOW TRACT MORPHOGENESIS 23 56 2.544e-06 2.805e-05
423 SPROUTING ANGIOGENESIS 20 45 2.628e-06 2.884e-05
424 SMOOTH MUSCLE CONTRACTION 20 45 2.628e-06 2.884e-05
425 NEGATIVE REGULATION OF MAPK CASCADE 44 145 2.668e-06 2.921e-05
426 POSITIVE REGULATION OF BINDING 40 127 2.686e-06 2.927e-05
427 POSITIVE REGULATION OF ORGAN GROWTH 18 38 2.686e-06 2.927e-05
428 EXOCYTOSIS 78 310 2.693e-06 2.928e-05
429 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 24 60 2.715e-06 2.945e-05
430 SYNAPTIC SIGNALING 100 424 2.739e-06 2.964e-05
431 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 90 372 2.827e-06 3.051e-05
432 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 28 76 2.876e-06 3.098e-05
433 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 63 236 3.072e-06 3.294e-05
434 IN UTERO EMBRYONIC DEVELOPMENT 78 311 3.069e-06 3.294e-05
435 REGULATION OF PROTEIN IMPORT 52 183 3.109e-06 3.325e-05
436 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 75 296 3.155e-06 3.367e-05
437 CYTOKINE MEDIATED SIGNALING PATHWAY 105 452 3.243e-06 3.453e-05
438 CELL MATRIX ADHESION 38 119 3.267e-06 3.471e-05
439 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 35 106 3.372e-06 3.574e-05
440 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 22 53 3.392e-06 3.579e-05
441 CELLULAR RESPONSE TO AMINO ACID STIMULUS 22 53 3.392e-06 3.579e-05
442 CELL FATE COMMITMENT 61 227 3.471e-06 3.654e-05
443 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 10 14 3.524e-06 3.701e-05
444 PROTEIN LOCALIZATION TO CELL PERIPHERY 45 151 3.541e-06 3.711e-05
445 RESPONSE TO CALCIUM ION 37 115 3.588e-06 3.752e-05
446 GLAND DEVELOPMENT 94 395 3.622e-06 3.779e-05
447 CYCLIC NUCLEOTIDE METABOLIC PROCESS 23 57 3.655e-06 3.796e-05
448 RENAL SYSTEM PROCESS 34 102 3.648e-06 3.796e-05
449 REGULATION OF LIPID METABOLIC PROCESS 72 282 3.676e-06 3.809e-05
450 INOSITOL LIPID MEDIATED SIGNALING 39 124 3.7e-06 3.826e-05
451 REGULATION OF CYTOSKELETON ORGANIZATION 114 502 3.941e-06 4.066e-05
452 HOMEOSTASIS OF NUMBER OF CELLS 50 175 4.021e-06 4.139e-05
453 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 56 204 4.263e-06 4.379e-05
454 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 18 39 4.282e-06 4.379e-05
455 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 39 4.282e-06 4.379e-05
456 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 21 50 4.506e-06 4.587e-05
457 REGULATION OF ADHERENS JUNCTION ORGANIZATION 21 50 4.506e-06 4.587e-05
458 REGULATION OF CYTOKINE PRODUCTION 125 563 4.539e-06 4.611e-05
459 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 15 29 4.63e-06 4.673e-05
460 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 29 4.63e-06 4.673e-05
461 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 15 29 4.63e-06 4.673e-05
462 REGULATION OF HEART RATE 30 86 4.736e-06 4.77e-05
463 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 73 289 4.777e-06 4.801e-05
464 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 11 17 4.871e-06 4.884e-05
465 CARDIAC CONDUCTION 29 82 4.97e-06 4.973e-05
466 LIPID PHOSPHORYLATION 33 99 5.041e-06 5.034e-05
467 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 59 220 5.33e-06 5.311e-05
468 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 24 62 5.364e-06 5.333e-05
469 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 32 95 5.429e-06 5.38e-05
470 POSITIVE REGULATION OF LIPASE ACTIVITY 25 66 5.434e-06 5.38e-05
471 INNERVATION 13 23 5.572e-06 5.505e-05
472 ADULT BEHAVIOR 41 135 5.626e-06 5.546e-05
473 VASCULAR PROCESS IN CIRCULATORY SYSTEM 47 163 5.89e-06 5.794e-05
474 REGULATION OF SYNAPTIC PLASTICITY 42 140 6.133e-06 6.02e-05
475 OVULATION CYCLE 36 113 6.217e-06 6.091e-05
476 NEGATIVE REGULATION OF CHEMOTAXIS 21 51 6.569e-06 6.422e-05
477 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 40 6.685e-06 6.507e-05
478 CALCIUM ION TRANSMEMBRANE TRANSPORT 46 159 6.681e-06 6.507e-05
479 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 172 829 6.756e-06 6.563e-05
480 EYE MORPHOGENESIS 41 136 6.887e-06 6.676e-05
481 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 27 75 7.123e-06 6.89e-05
482 REGULATION OF CELLULAR PROTEIN LOCALIZATION 122 552 7.408e-06 7.151e-05
483 T CELL DIFFERENTIATION 38 123 7.838e-06 7.55e-05
484 CELLULAR RESPONSE TO INSULIN STIMULUS 43 146 8.033e-06 7.723e-05
485 SKELETAL MUSCLE ORGAN DEVELOPMENT 41 137 8.404e-06 8.062e-05
486 TISSUE MIGRATION 29 84 8.553e-06 8.181e-05
487 POSITIVE REGULATION OF GROWTH 62 238 8.562e-06 8.181e-05
488 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 20 48 8.763e-06 8.355e-05
489 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 10 15 9.126e-06 8.648e-05
490 REGULATION OF HEAT GENERATION 10 15 9.126e-06 8.648e-05
491 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 45 156 9.098e-06 8.648e-05
492 CARDIAC VENTRICLE DEVELOPMENT 34 106 9.44e-06 8.928e-05
493 MULTICELLULAR ORGANISM METABOLIC PROCESS 31 93 9.638e-06 9.096e-05
494 LIPID LOCALIZATION 67 264 9.743e-06 9.177e-05
495 ENDOTHELIAL CELL DIFFERENTIATION 26 72 9.815e-06 9.226e-05
496 REPRODUCTION 252 1297 1.037e-05 9.726e-05
497 RESPONSE TO OXIDATIVE STRESS 84 352 1.044e-05 9.77e-05
498 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 13 24 1.047e-05 9.779e-05
499 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 16 34 1.073e-05 9.982e-05
500 CAMP METABOLIC PROCESS 16 34 1.073e-05 9.982e-05
501 RESPONSE TO INSULIN 55 205 1.078e-05 0.0001001
502 PALATE DEVELOPMENT 29 85 1.112e-05 0.000103
503 EPITHELIAL CELL DEVELOPMENT 51 186 1.158e-05 0.0001072
504 PLATELET DEGRANULATION 34 107 1.184e-05 0.0001093
505 RESPONSE TO ORGANOPHOSPHORUS 41 139 1.24e-05 0.000114
506 REGULATION OF CELL SHAPE 41 139 1.24e-05 0.000114
507 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 48 172 1.243e-05 0.0001141
508 REGULATION OF BMP SIGNALING PATHWAY 27 77 1.248e-05 0.0001143
509 CARDIAC CELL DEVELOPMENT 20 49 1.27e-05 0.0001161
510 ENDOCYTOSIS 113 509 1.289e-05 0.0001176
511 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 17 38 1.325e-05 0.0001207
512 MESONEPHROS DEVELOPMENT 30 90 1.333e-05 0.0001212
513 CELLULAR RESPONSE TO BIOTIC STIMULUS 46 163 1.364e-05 0.0001237
514 ENDOTHELIAL CELL MIGRATION 22 57 1.383e-05 0.0001252
515 POSITIVE REGULATION OF STEM CELL PROLIFERATION 23 61 1.396e-05 0.0001261
516 REGULATION OF PROTEIN BINDING 47 168 1.42e-05 0.000128
517 REGULATION OF HORMONE SECRETION 66 262 1.464e-05 0.0001318
518 REGULATION OF HORMONE LEVELS 107 478 1.493e-05 0.0001341
519 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 37 122 1.632e-05 0.0001463
520 RESPONSE TO MONOAMINE 16 35 1.698e-05 0.000152
521 REGULATION OF ACUTE INFLAMMATORY RESPONSE 26 74 1.725e-05 0.0001541
522 NEGATIVE REGULATION OF CELL ADHESION 58 223 1.73e-05 0.0001542
523 RHO PROTEIN SIGNAL TRANSDUCTION 20 50 1.817e-05 0.0001617
524 CELLULAR RESPONSE TO OXIDATIVE STRESS 50 184 1.83e-05 0.0001625
525 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 66 1.864e-05 0.0001646
526 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 66 1.864e-05 0.0001646
527 REGULATION OF CARDIAC CONDUCTION 24 66 1.864e-05 0.0001646
528 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 13 25 1.877e-05 0.0001655
529 REGULATION OF ENDOCYTOSIS 53 199 1.929e-05 0.0001697
530 REGULATION OF PEPTIDE SECRETION 55 209 1.969e-05 0.0001729
531 REGULATION OF POTASSIUM ION TRANSPORT 28 83 1.988e-05 0.0001742
532 TRABECULA MORPHOGENESIS 17 39 2.018e-05 0.0001765
533 NEURON CELL CELL ADHESION 10 16 2.101e-05 0.0001834
534 DENDRITE DEVELOPMENT 27 79 2.129e-05 0.0001851
535 REGULATION OF SYNAPSE ASSEMBLY 27 79 2.129e-05 0.0001851
536 CELL JUNCTION ORGANIZATION 50 185 2.143e-05 0.000186
537 ADIPOSE TISSUE DEVELOPMENT 15 32 2.147e-05 0.000186
538 REGENERATION 45 161 2.193e-05 0.0001897
539 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 19 2.213e-05 0.0001907
540 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 11 19 2.213e-05 0.0001907
541 REGULATION OF EXTENT OF CELL GROWTH 32 101 2.257e-05 0.0001939
542 POSITIVE REGULATION OF AUTOPHAGY 26 75 2.263e-05 0.0001939
543 NEURAL CREST CELL DIFFERENTIATION 26 75 2.263e-05 0.0001939
544 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 18 43 2.271e-05 0.0001943
545 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 34 110 2.278e-05 0.0001945
546 REGULATION OF COAGULATION 29 88 2.357e-05 0.0002001
547 OVULATION CYCLE PROCESS 29 88 2.357e-05 0.0002001
548 REGULATION OF STEM CELL PROLIFERATION 29 88 2.357e-05 0.0002001
549 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 31 97 2.489e-05 0.0002109
550 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 35 115 2.512e-05 0.0002126
551 RESPONSE TO REACTIVE OXYGEN SPECIES 51 191 2.545e-05 0.0002149
552 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 28 84 2.554e-05 0.0002153
553 NEURAL CREST CELL MIGRATION 20 51 2.566e-05 0.0002159
554 POSITIVE REGULATION OF RESPONSE TO WOUNDING 45 162 2.596e-05 0.0002181
555 RAS PROTEIN SIGNAL TRANSDUCTION 41 143 2.607e-05 0.0002182
556 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 41 143 2.607e-05 0.0002182
557 CELL JUNCTION ASSEMBLY 38 129 2.62e-05 0.0002189
558 CARDIAC MUSCLE CELL CONTRACTION 14 29 2.667e-05 0.0002224
559 ACTIN FILAMENT BASED MOVEMENT 30 93 2.735e-05 0.0002277
560 REGULATION OF CELL SIZE 47 172 2.754e-05 0.0002288
561 REGULATION OF FEVER GENERATION 8 11 2.972e-05 0.0002465
562 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 82 351 2.995e-05 0.0002479
563 POSITIVE REGULATION OF MAP KINASE ACTIVITY 54 207 3.032e-05 0.0002506
564 MEMORY 31 98 3.117e-05 0.0002558
565 REGULATION OF JAK STAT CASCADE 41 144 3.117e-05 0.0002558
566 MYELOID LEUKOCYTE ACTIVATION 31 98 3.117e-05 0.0002558
567 REGULATION OF STAT CASCADE 41 144 3.117e-05 0.0002558
568 REGULATION OF AMINE TRANSPORT 25 72 3.132e-05 0.0002566
569 REGULATION OF SEQUESTERING OF CALCIUM ION 33 107 3.139e-05 0.0002567
570 REGULATION OF CELL CYCLE 189 949 3.209e-05 0.000262
571 GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 13 26 3.234e-05 0.0002635
572 CARDIAC SEPTUM DEVELOPMENT 28 85 3.263e-05 0.0002654
573 RESPONSE TO BMP 30 94 3.44e-05 0.0002784
574 CELLULAR RESPONSE TO BMP STIMULUS 30 94 3.44e-05 0.0002784
575 DEVELOPMENTAL MATURATION 51 193 3.441e-05 0.0002784
576 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 48 3.486e-05 0.0002811
577 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 19 48 3.486e-05 0.0002811
578 REGULATION OF CIRCADIAN RHYTHM 32 103 3.497e-05 0.0002812
579 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 56 218 3.499e-05 0.0002812
580 METANEPHROS DEVELOPMENT 27 81 3.538e-05 0.0002836
581 REGULATION OF SMOOTH MUSCLE CONTRACTION 22 60 3.541e-05 0.0002836
582 ACTIVATION OF MAPKK ACTIVITY 20 52 3.578e-05 0.0002861
583 CELLULAR RESPONSE TO EXTERNAL STIMULUS 65 264 3.638e-05 0.0002903
584 REGULATION OF CELLULAR COMPONENT SIZE 79 337 3.658e-05 0.0002915
585 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 41 145 3.717e-05 0.0002956
586 REGULATION OF METANEPHROS DEVELOPMENT 12 23 3.794e-05 0.0003012
587 REGULATION OF SODIUM ION TRANSPORT 26 77 3.814e-05 0.0003023
588 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 16 37 3.98e-05 0.0003139
589 CARDIAC MUSCLE CELL ACTION POTENTIAL 16 37 3.98e-05 0.0003139
590 AXON EXTENSION 16 37 3.98e-05 0.0003139
591 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 14 4.055e-05 0.0003192
592 POSITIVE REGULATION OF SECRETION 85 370 4.129e-05 0.0003246
593 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 149 724 4.223e-05 0.0003313
594 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 11 20 4.242e-05 0.0003323
595 REGULATION OF CELL ACTIVATION 106 484 4.259e-05 0.0003331
596 SMOOTH MUSCLE CELL DIFFERENTIATION 14 30 4.303e-05 0.0003354
597 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 14 30 4.303e-05 0.0003354
598 NEGATIVE REGULATION OF ION TRANSPORT 37 127 4.328e-05 0.0003367
599 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 17 41 4.427e-05 0.0003428
600 REGULATION OF MEMBRANE DEPOLARIZATION 17 41 4.427e-05 0.0003428
601 AORTA DEVELOPMENT 17 41 4.427e-05 0.0003428
602 IMMUNE RESPONSE 214 1100 4.504e-05 0.0003481
603 INTEGRIN MEDIATED SIGNALING PATHWAY 27 82 4.52e-05 0.0003488
604 B CELL ACTIVATION 38 132 4.586e-05 0.0003533
605 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 22 61 4.751e-05 0.0003654
606 REGULATION OF PEPTIDE TRANSPORT 63 256 4.827e-05 0.0003706
607 RESPONSE TO DRUG 96 431 4.907e-05 0.0003761
608 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 20 53 4.933e-05 0.0003763
609 CYTOSOLIC CALCIUM ION TRANSPORT 20 53 4.933e-05 0.0003763
610 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 20 53 4.933e-05 0.0003763
611 DEFENSE RESPONSE 236 1231 4.963e-05 0.0003779
612 PROTEIN LOCALIZATION 332 1805 5.084e-05 0.0003859
613 NEGATIVE REGULATION OF NEURON DEATH 46 171 5.081e-05 0.0003859
614 RESPONSE TO FLUID SHEAR STRESS 15 34 5.211e-05 0.0003943
615 REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 34 5.211e-05 0.0003943
616 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 13 27 5.372e-05 0.0004044
617 HIPPO SIGNALING 13 27 5.372e-05 0.0004044
618 REGULATION OF CATENIN IMPORT INTO NUCLEUS 13 27 5.372e-05 0.0004044
619 MUSCLE ORGAN MORPHOGENESIS 24 70 5.659e-05 0.0004247
620 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 24 70 5.659e-05 0.0004247
621 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 44 162 5.717e-05 0.0004276
622 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 44 162 5.717e-05 0.0004276
623 FORMATION OF PRIMARY GERM LAYER 33 110 5.81e-05 0.0004339
624 POSITIVE REGULATION OF CATABOLIC PROCESS 89 395 5.871e-05 0.0004378
625 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 16 38 5.911e-05 0.0004394
626 REGULATION OF RENAL SYSTEM PROCESS 16 38 5.911e-05 0.0004394
627 REGULATION OF VASOCONSTRICTION 23 66 6.009e-05 0.0004459
628 APOPTOTIC SIGNALING PATHWAY 69 289 6.06e-05 0.000449
629 RESPONSE TO KETONE 48 182 6.071e-05 0.0004491
630 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 51 197 6.154e-05 0.0004545
631 REGULATION OF STRIATED MUSCLE CONTRACTION 26 79 6.264e-05 0.0004619
632 CARDIAC VENTRICLE MORPHOGENESIS 22 62 6.318e-05 0.0004651
633 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 42 153 6.393e-05 0.0004699
634 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 24 6.541e-05 0.00048
635 INTERACTION WITH HOST 38 134 6.561e-05 0.0004808
636 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 14 31 6.755e-05 0.0004942
637 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 19 50 6.771e-05 0.0004946
638 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 50 193 7.086e-05 0.0005152
639 POSITIVE REGULATION OF CYTOKINE PRODUCTION 84 370 7.085e-05 0.0005152
640 NEGATIVE REGULATION OF CATABOLIC PROCESS 52 203 7.07e-05 0.0005152
641 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 27 84 7.25e-05 0.0005263
642 NEPHRON EPITHELIUM DEVELOPMENT 29 93 7.408e-05 0.0005369
643 RESPONSE TO EXTRACELLULAR STIMULUS 97 441 7.446e-05 0.0005388
644 RESPONSE TO FIBROBLAST GROWTH FACTOR 34 116 7.593e-05 0.0005478
645 FEMALE SEX DIFFERENTIATION 34 116 7.593e-05 0.0005478
646 CHONDROCYTE DEVELOPMENT 11 21 7.686e-05 0.0005536
647 REGULATION OF BROWN FAT CELL DIFFERENTIATION 8 12 7.723e-05 0.0005537
648 CARTILAGE MORPHOGENESIS 8 12 7.723e-05 0.0005537
649 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 7.723e-05 0.0005537
650 REGULATION OF PROTEIN KINASE B SIGNALING 35 121 8.073e-05 0.0005779
651 POST EMBRYONIC DEVELOPMENT 28 89 8.226e-05 0.000588
652 REGULATION OF MUSCLE ADAPTATION 22 63 8.329e-05 0.0005944
653 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 10 18 8.566e-05 0.0006094
654 INOSITOL PHOSPHATE MEDIATED SIGNALING 10 18 8.566e-05 0.0006094
655 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 13 28 8.638e-05 0.0006127
656 REGULATION OF FATTY ACID OXIDATION 13 28 8.638e-05 0.0006127
657 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 9 15 8.768e-05 0.000621
658 INFLAMMATORY RESPONSE 99 454 8.922e-05 0.0006302
659 ENDOMEMBRANE SYSTEM ORGANIZATION 101 465 8.925e-05 0.0006302
660 WNT SIGNALING PATHWAY 80 351 9.059e-05 0.0006387
661 CEREBRAL CORTEX CELL MIGRATION 17 43 9.087e-05 0.0006397
662 HEART PROCESS 27 85 9.106e-05 0.00064
663 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 34 117 9.163e-05 0.0006431
664 ARTERY MORPHOGENESIS 19 51 9.268e-05 0.0006495
665 GLIOGENESIS 46 175 9.316e-05 0.0006518
666 PROTEIN DEPHOSPHORYLATION 49 190 9.401e-05 0.0006568
667 ION TRANSMEMBRANE TRANSPORT 164 822 9.618e-05 0.000671
668 NEGATIVE REGULATION OF CELL CYCLE 95 433 9.688e-05 0.0006748
669 NEGATIVE REGULATION OF PROTEIN SECRETION 32 108 9.71e-05 0.0006754
670 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 26 81 0.0001004 0.0006974
671 ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 23 68 0.0001017 0.0007044
672 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 23 68 0.0001017 0.0007044
673 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 28 90 0.0001023 0.0007075
674 SALIVARY GLAND DEVELOPMENT 14 32 0.0001034 0.0007116
675 ENDOCARDIAL CUSHION DEVELOPMENT 14 32 0.0001034 0.0007116
676 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 14 32 0.0001034 0.0007116
677 REGULATION OF NEURON DEATH 61 252 0.0001043 0.0007166
678 MEMBRANE ASSEMBLY 12 25 0.0001084 0.0007432
679 CELLULAR EXTRAVASATION 12 25 0.0001084 0.0007432
680 HINDBRAIN DEVELOPMENT 38 137 0.0001099 0.0007519
681 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 34 118 0.0001102 0.000753
682 NEUROMUSCULAR JUNCTION DEVELOPMENT 15 36 0.0001157 0.0007862
683 REGULATION OF GLUCOSE IMPORT 21 60 0.0001155 0.0007862
684 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 15 36 0.0001157 0.0007862
685 CORTICAL CYTOSKELETON ORGANIZATION 15 36 0.0001157 0.0007862
686 RESPONSE TO HYDROGEN PEROXIDE 32 109 0.0001177 0.0007985
687 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 24 73 0.0001205 0.0008161
688 SMAD PROTEIN SIGNAL TRANSDUCTION 20 56 0.0001212 0.0008197
689 PEPTIDYL TYROSINE DEPHOSPHORYLATION 30 100 0.0001235 0.0008341
690 REGULATION OF EMBRYONIC DEVELOPMENT 33 114 0.0001252 0.0008445
691 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 171 867 0.0001273 0.0008551
692 NEGATIVE REGULATION OF JAK STAT CASCADE 17 44 0.0001273 0.0008551
693 NEGATIVE REGULATION OF STAT CASCADE 17 44 0.0001273 0.0008551
694 REGULATION OF ORGANELLE ORGANIZATION 224 1178 0.0001284 0.0008612
695 GLYCOSPHINGOLIPID METABOLIC PROCESS 23 69 0.0001309 0.0008752
696 POSITIVE REGULATION OF AXONOGENESIS 23 69 0.0001309 0.0008752
697 NEGATIVE REGULATION OF MUSCLE CONTRACTION 11 22 0.0001327 0.0008845
698 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 11 22 0.0001327 0.0008845
699 RESPONSE TO ESTROGEN 54 218 0.0001345 0.0008941
700 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 54 218 0.0001345 0.0008941
701 STEM CELL DIVISION 13 29 0.0001349 0.0008941
702 NEGATIVE REGULATION OF RECEPTOR ACTIVITY 13 29 0.0001349 0.0008941
703 MYELOID LEUKOCYTE DIFFERENTIATION 29 96 0.000139 0.0009198
704 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001414 0.000924
705 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001414 0.000924
706 HORMONE MEDIATED SIGNALING PATHWAY 42 158 0.0001405 0.000924
707 VIRAL ENTRY INTO HOST CELL 27 87 0.0001414 0.000924
708 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001414 0.000924
709 TISSUE REMODELING 27 87 0.0001414 0.000924
710 MOVEMENT IN HOST ENVIRONMENT 27 87 0.0001414 0.000924
711 ENTRY INTO HOST 27 87 0.0001414 0.000924
712 ENTRY INTO HOST CELL 27 87 0.0001414 0.000924
713 CELLULAR MACROMOLECULE LOCALIZATION 233 1234 0.0001469 0.0009584
714 CAMERA TYPE EYE MORPHOGENESIS 30 101 0.0001505 0.000981
715 REGULATION OF DENDRITE MORPHOGENESIS 24 74 0.000153 0.0009941
716 ACTIN MEDIATED CELL CONTRACTION 24 74 0.000153 0.0009941
717 NEURON RECOGNITION 14 33 0.0001546 0.001002
718 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 14 33 0.0001546 0.001002
719 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 10 19 0.0001563 0.00101
720 GLOMERULAR EPITHELIUM DEVELOPMENT 10 19 0.0001563 0.00101
721 SEX DIFFERENTIATION 63 266 0.0001576 0.001017
722 CYTOKINE PRODUCTION 34 120 0.0001578 0.001017
723 AMMONIUM TRANSPORT 20 57 0.0001603 0.001032
724 STEROID HORMONE MEDIATED SIGNALING PATHWAY 35 125 0.0001644 0.001057
725 MYOBLAST DIFFERENTIATION 15 37 0.0001675 0.001072
726 REGULATION OF MUSCLE HYPERTROPHY 15 37 0.0001675 0.001072
727 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 15 37 0.0001675 0.001072
728 NEURON PROJECTION EXTENSION 19 53 0.000168 0.001074
729 ACTIN FILAMENT BUNDLE ORGANIZATION 18 49 0.0001735 0.001097
730 HEART TRABECULA MORPHOGENESIS 12 26 0.0001737 0.001097
731 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 9 16 0.0001734 0.001097
732 EXTRACELLULAR MATRIX ASSEMBLY 9 16 0.0001734 0.001097
733 REGULATION OF MONONUCLEAR CELL MIGRATION 9 16 0.0001734 0.001097
734 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 12 26 0.0001737 0.001097
735 VASODILATION 12 26 0.0001737 0.001097
736 REGULATION OF AMINO ACID TRANSPORT 12 26 0.0001737 0.001097
737 CARDIAC SEPTUM MORPHOGENESIS 18 49 0.0001735 0.001097
738 CARDIOBLAST DIFFERENTIATION 8 13 0.000174 0.001097
739 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 25 79 0.0001746 0.001098
740 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 25 79 0.0001746 0.001098
741 POSITIVE REGULATION OF RECEPTOR ACTIVITY 17 45 0.0001759 0.001102
742 EXOCRINE SYSTEM DEVELOPMENT 17 45 0.0001759 0.001102
743 ENDOCHONDRAL BONE MORPHOGENESIS 17 45 0.0001759 0.001102
744 PATTERN SPECIFICATION PROCESS 91 418 0.0001786 0.001117
745 REGULATION OF NEUROTRANSMITTER LEVELS 48 190 0.0001876 0.001172
746 NEGATIVE REGULATION OF IMMUNE RESPONSE 34 121 0.0001879 0.001172
747 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 24 75 0.000193 0.0012
748 MULTI ORGANISM BEHAVIOR 24 75 0.000193 0.0012
749 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 53 216 0.0001993 0.001238
750 CELL MATURATION 36 131 0.000201 0.001247
751 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 84 381 0.0002013 0.001247
752 POSITIVE REGULATION OF PROTEIN SECRETION 52 211 0.0002028 0.001253
753 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 52 211 0.0002028 0.001253
754 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 13 30 0.0002051 0.001263
755 RESPONSE TO AMINO ACID 32 112 0.0002052 0.001263
756 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 13 30 0.0002051 0.001263
757 GLIAL CELL DIFFERENTIATION 37 136 0.0002061 0.001267
758 LIPID METABOLIC PROCESS 219 1158 0.0002109 0.001295
759 REGULATION OF IMMUNE RESPONSE 168 858 0.0002112 0.001295
760 LEUKOCYTE CHEMOTAXIS 33 117 0.0002147 0.001315
761 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 41 156 0.0002182 0.001334
762 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 11 23 0.0002195 0.00134
763 CARDIAC MUSCLE TISSUE MORPHOGENESIS 19 54 0.0002227 0.001358
764 FOREBRAIN NEURON DEVELOPMENT 14 34 0.0002264 0.001377
765 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 14 34 0.0002264 0.001377
766 VISUAL BEHAVIOR 18 50 0.0002329 0.001415
767 REGULATION OF ACTION POTENTIAL 15 38 0.0002382 0.001441
768 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 15 38 0.0002382 0.001441
769 REGULATION OF PROTEIN TARGETING 70 307 0.0002378 0.001441
770 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 17 46 0.0002399 0.00145
771 NEGATIVE REGULATION OF GTPASE ACTIVITY 16 42 0.0002422 0.001462
772 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 40 152 0.0002513 0.001515
773 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 44 172 0.0002526 0.001521
774 RESPONSE TO CAMP 30 104 0.000266 0.001597
775 REGULATION OF INTERLEUKIN 6 PRODUCTION 30 104 0.000266 0.001597
776 RESPONSE TO PROTOZOAN 10 20 0.0002701 0.001613
777 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 12 27 0.0002697 0.001613
778 SUBSTRATE DEPENDENT CELL MIGRATION 12 27 0.0002697 0.001613
779 MELANOCYTE DIFFERENTIATION 10 20 0.0002701 0.001613
780 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 35 128 0.0002715 0.00162
781 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 20 59 0.0002731 0.001625
782 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 20 59 0.0002731 0.001625
783 PLACENTA DEVELOPMENT 37 138 0.0002827 0.00168
784 REGULATION OF KIDNEY DEVELOPMENT 19 55 0.0002923 0.00173
785 CRANIAL SKELETAL SYSTEM DEVELOPMENT 19 55 0.0002923 0.00173
786 NEGATIVE REGULATION OF CELL ACTIVATION 41 158 0.0002921 0.00173
787 NERVE DEVELOPMENT 22 68 0.0002949 0.001744
788 METENCEPHALON DEVELOPMENT 29 100 0.0003025 0.001786
789 MACROPHAGE ACTIVATION 13 31 0.0003045 0.001796
790 REGULATION OF DOPAMINE METABOLIC PROCESS 9 17 0.0003189 0.00187
791 NEGATIVE REGULATION OF PLATELET ACTIVATION 9 17 0.0003189 0.00187
792 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 9 17 0.0003189 0.00187
793 REGULATION OF CATECHOLAMINE METABOLIC PROCESS 9 17 0.0003189 0.00187
794 ODONTOGENESIS 30 105 0.0003191 0.00187
795 ENSHEATHMENT OF NEURONS 27 91 0.0003212 0.001878
796 AXON ENSHEATHMENT 27 91 0.0003212 0.001878
797 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 17 47 0.0003232 0.001887
798 REGULATION OF AXON GUIDANCE 15 39 0.0003332 0.001938
799 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 15 39 0.0003332 0.001938
800 LONG TERM SYNAPTIC POTENTIATION 15 39 0.0003332 0.001938
801 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 23 73 0.0003354 0.001946
802 ASSOCIATIVE LEARNING 23 73 0.0003354 0.001946
803 LIPID MODIFICATION 51 210 0.0003384 0.001961
804 NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 11 0.0003436 0.001986
805 NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 7 11 0.0003436 0.001986
806 STRESS FIBER ASSEMBLY 8 14 0.000352 0.002007
807 CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY 8 14 0.000352 0.002007
808 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 11 24 0.0003499 0.002007
809 REGULATION OF GLOMERULUS DEVELOPMENT 8 14 0.000352 0.002007
810 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 20 60 0.0003518 0.002007
811 POSITIVE REGULATION OF FATTY ACID OXIDATION 8 14 0.000352 0.002007
812 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 20 60 0.0003518 0.002007
813 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 11 24 0.0003499 0.002007
814 CAMP CATABOLIC PROCESS 8 14 0.000352 0.002007
815 CRANIOFACIAL SUTURE MORPHOGENESIS 8 14 0.000352 0.002007
816 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 8 14 0.000352 0.002007
817 POSITIVE REGULATION OF CHEMOTAXIS 33 120 0.0003575 0.002036
818 MULTI ORGANISM REPRODUCTIVE PROCESS 172 891 0.0003669 0.002087
819 RESPONSE TO ACTIVITY 22 69 0.0003717 0.002112
820 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 52 216 0.0003728 0.002116
821 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 36 135 0.0003797 0.002149
822 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 36 135 0.0003797 0.002149
823 PROTEIN HOMOOLIGOMERIZATION 58 248 0.0003962 0.00224
824 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 18 52 0.0004069 0.002288
825 RIBONUCLEOTIDE CATABOLIC PROCESS 12 28 0.0004071 0.002288
826 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 12 28 0.0004071 0.002288
827 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 52 0.0004069 0.002288
828 REGULATION OF LIPID CATABOLIC PROCESS 18 52 0.0004069 0.002288
829 REGULATION OF CHEMOKINE PRODUCTION 21 65 0.00041 0.002301
830 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 23 74 0.0004177 0.002342
831 OSTEOBLAST DIFFERENTIATION 34 126 0.00043 0.002407
832 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 17 48 0.0004304 0.002407
833 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 29 102 0.0004355 0.002433
834 RETINA DEVELOPMENT IN CAMERA TYPE EYE 35 131 0.000437 0.002438
835 REGULATION OF AUTOPHAGY 58 249 0.0004415 0.002452
836 MYELOID CELL HOMEOSTASIS 26 88 0.0004418 0.002452
837 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 13 32 0.0004421 0.002452
838 BLOOD VESSEL REMODELING 13 32 0.0004421 0.002452
839 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 32 0.0004421 0.002452
840 CELL AGGREGATION 10 21 0.0004457 0.00246
841 LIPID TRANSLOCATION 10 21 0.0004457 0.00246
842 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 21 0.0004457 0.00246
843 CARTILAGE CONDENSATION 10 21 0.0004457 0.00246
844 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 14 36 0.0004581 0.002523
845 POSITIVE REGULATION OF AXON EXTENSION 14 36 0.0004581 0.002523
846 POSITIVE REGULATION OF CELL MATRIX ADHESION 15 40 0.0004591 0.002525
847 REGULATION OF NEURON APOPTOTIC PROCESS 47 192 0.0004686 0.002574
848 EAR MORPHOGENESIS 31 112 0.0004702 0.00258
849 RESPONSE TO RADIATION 88 413 0.0004743 0.002599
850 REGULATION OF CELL CELL ADHESION 82 380 0.0004839 0.002649
851 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 33 122 0.0004944 0.002703
852 CIRCADIAN RHYTHM 36 137 0.0005136 0.002805
853 SENSORY PERCEPTION OF PAIN 23 75 0.0005171 0.002821
854 REGULATION OF CALCIUM ION IMPORT 29 103 0.0005197 0.002831
855 SINGLE ORGANISM CELLULAR LOCALIZATION 172 898 0.0005382 0.002929
856 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 25 0.0005397 0.002934
857 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 46 188 0.0005406 0.002935
858 OVULATION 9 18 0.0005521 0.002994
859 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 17 49 0.0005669 0.003071
860 LUNG MORPHOGENESIS 16 45 0.0005993 0.003242
861 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 29 104 0.0006178 0.003338
862 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 15 41 0.0006234 0.003361
863 GOLGI TO PLASMA MEMBRANE TRANSPORT 15 41 0.0006234 0.003361
864 NEGATIVE REGULATION OF WOUND HEALING 19 58 0.0006264 0.003373
865 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 13 33 0.000629 0.003384
866 ACTIN POLYMERIZATION OR DEPOLYMERIZATION 14 37 0.000635 0.003408
867 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 14 37 0.000635 0.003408
868 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 8 15 0.000654 0.003506
869 PROTEIN OLIGOMERIZATION 91 434 0.0006644 0.003557
870 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 33 124 0.0006758 0.003615
871 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 27 95 0.0006791 0.003628
872 REGULATION OF LEUKOCYTE MIGRATION 38 149 0.000684 0.003646
873 REGULATION OF CYTOKINE SECRETION 38 149 0.000684 0.003646
874 PROTEIN COMPLEX SUBUNIT ORGANIZATION 276 1527 0.0006951 0.003701
875 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 10 22 0.0007066 0.003736
876 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 10 22 0.0007066 0.003736
877 SOMATIC STEM CELL DIVISION 10 22 0.0007066 0.003736
878 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 10 22 0.0007066 0.003736
879 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 10 22 0.0007066 0.003736
880 MONOAMINE TRANSPORT 10 22 0.0007066 0.003736
881 LIMBIC SYSTEM DEVELOPMENT 28 100 0.0007077 0.003738
882 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 7 12 0.0007165 0.003758
883 ROUNDABOUT SIGNALING PATHWAY 7 12 0.0007165 0.003758
884 AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 12 0.0007165 0.003758
885 REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 7 12 0.0007165 0.003758
886 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 7 12 0.0007165 0.003758
887 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 7 12 0.0007165 0.003758
888 RESPONSE TO OSMOTIC STRESS 20 63 0.000718 0.003758
889 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 20 63 0.000718 0.003758
890 CELLULAR RESPONSE TO CAMP 17 50 0.000739 0.003855
891 STAT CASCADE 17 50 0.000739 0.003855
892 JAK STAT CASCADE 17 50 0.000739 0.003855
893 GASTRULATION 39 155 0.0007772 0.00405
894 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 23 77 0.0007793 0.004056
895 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 26 0.0008081 0.004201
896 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 15 42 0.0008351 0.004318
897 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 15 42 0.0008351 0.004318
898 DENDRITE MORPHOGENESIS 15 42 0.0008351 0.004318
899 POSITIVE REGULATION OF GLUCOSE TRANSPORT 15 42 0.0008351 0.004318
900 CALCIUM ION IMPORT INTO CYTOSOL 15 42 0.0008351 0.004318
901 RESPONSE TO BACTERIUM 107 528 0.0008514 0.004397
902 MEMBRANE BIOGENESIS 12 30 0.0008621 0.004427
903 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 12 30 0.0008621 0.004427
904 BROWN FAT CELL DIFFERENTIATION 12 30 0.0008621 0.004427
905 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 12 30 0.0008621 0.004427
906 OSTEOCLAST DIFFERENTIATION 12 30 0.0008621 0.004427
907 TRANSITION METAL ION HOMEOSTASIS 29 106 0.0008637 0.004431
908 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 14 38 0.0008665 0.00444
909 CELLULAR LIPID METABOLIC PROCESS 173 913 0.0008682 0.004444
910 PROTEIN AUTOPHOSPHORYLATION 46 192 0.0008751 0.004475
911 POSITIVE REGULATION OF SODIUM ION TRANSPORT 13 34 0.0008783 0.004486
912 CELLULAR RESPONSE TO KETONE 22 73 0.00088 0.00449
913 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 30 111 0.0008827 0.004498
914 REGULATION OF FATTY ACID METABOLIC PROCESS 25 87 0.0008851 0.004501
915 TRANSMEMBRANE TRANSPORT 204 1098 0.0008851 0.004501
916 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 9 19 0.0009084 0.004604
917 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 9 19 0.0009084 0.004604
918 FIBRIL ORGANIZATION 9 19 0.0009084 0.004604
919 INNER EAR MORPHOGENESIS 26 92 0.0009276 0.004696
920 RENAL TUBULE DEVELOPMENT 23 78 0.0009489 0.004799
921 STEM CELL PROLIFERATION 19 60 0.0009992 0.005043
922 LEUKOCYTE HOMEOSTASIS 19 60 0.0009992 0.005043
923 EMBRYONIC PLACENTA DEVELOPMENT 24 83 0.001009 0.005082
924 RESPONSE TO FATTY ACID 24 83 0.001009 0.005082
925 AMINOGLYCAN BIOSYNTHETIC PROCESS 29 107 0.001016 0.00511
926 INTRINSIC APOPTOTIC SIGNALING PATHWAY 38 152 0.001025 0.00515
927 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 37 147 0.001037 0.005205
928 GLYCEROLIPID METABOLIC PROCESS 76 356 0.001047 0.005251
929 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 33 127 0.001057 0.005296
930 ESTABLISHMENT OF CELL POLARITY 25 88 0.001061 0.005303
931 LEUKOCYTE PROLIFERATION 25 88 0.001061 0.005303
932 NEGATIVE REGULATION OF HORMONE SECRETION 22 74 0.001076 0.00537
933 REGULATION OF OSTEOBLAST PROLIFERATION 10 23 0.001081 0.005381
934 TRABECULA FORMATION 10 23 0.001081 0.005381
935 STRIATED MUSCLE ADAPTATION 10 23 0.001081 0.005381
936 ANTERIOR POSTERIOR PATTERN SPECIFICATION 46 194 0.001103 0.005482
937 REGULATION OF DENDRITIC SPINE DEVELOPMENT 18 56 0.001107 0.005492
938 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 41 168 0.001107 0.005492
939 DENDRITIC CELL CHEMOTAXIS 8 16 0.001135 0.005575
940 MORPHOGENESIS OF AN ENDOTHELIUM 8 16 0.001135 0.005575
941 REGULATION OF MACROPHAGE CHEMOTAXIS 8 16 0.001135 0.005575
942 RESPONSE TO EPINEPHRINE 8 16 0.001135 0.005575
943 STRIATUM DEVELOPMENT 8 16 0.001135 0.005575
944 CELLULAR RESPONSE TO LEPTIN STIMULUS 8 16 0.001135 0.005575
945 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 8 16 0.001135 0.005575
946 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 8 16 0.001135 0.005575
947 REGULATION OF FATTY ACID BETA OXIDATION 8 16 0.001135 0.005575
948 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 27 98 0.001141 0.005598
949 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 14 39 0.001165 0.005713
950 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 11 27 0.001178 0.005741
951 EXCITATORY POSTSYNAPTIC POTENTIAL 11 27 0.001178 0.005741
952 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 11 27 0.001178 0.005741
953 AXIS ELONGATION 11 27 0.001178 0.005741
954 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 11 27 0.001178 0.005741
955 REGULATION OF APOPTOTIC SIGNALING PATHWAY 77 363 0.001178 0.005741
956 MUCOPOLYSACCHARIDE METABOLIC PROCESS 29 108 0.001191 0.005796
957 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 47 200 0.001199 0.005828
958 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 13 35 0.001205 0.005854
959 REGULATION OF ANION TRANSPORT 35 138 0.001209 0.005866
960 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 65 297 0.00121 0.005867
961 MATERNAL PLACENTA DEVELOPMENT 12 31 0.001214 0.005879
962 NEURAL PRECURSOR CELL PROLIFERATION 21 70 0.001217 0.005881
963 MESODERM DEVELOPMENT 31 118 0.001216 0.005881
964 REGULATION OF PHOSPHATASE ACTIVITY 33 128 0.001221 0.005893
965 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 19 61 0.001248 0.006017
966 REGULATION OF VASCULOGENESIS 7 13 0.001349 0.006413
967 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 7 13 0.001349 0.006413
968 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 7 13 0.001349 0.006413
969 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 0.001349 0.006413
970 NEGATIVE REGULATION OF COAGULATION 16 48 0.001333 0.006413
971 LEUKOCYTE TETHERING OR ROLLING 7 13 0.001349 0.006413
972 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 7 13 0.001349 0.006413
973 POSITIVE REGULATION OF WOUND HEALING 16 48 0.001333 0.006413
974 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 7 13 0.001349 0.006413
975 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 7 13 0.001349 0.006413
976 NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 7 13 0.001349 0.006413
977 EXTRACELLULAR FIBRIL ORGANIZATION 7 13 0.001349 0.006413
978 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 7 13 0.001349 0.006413
979 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 7 13 0.001349 0.006413
980 REGULATION OF MULTICELLULAR ORGANISM GROWTH 20 66 0.001374 0.006511
981 MESODERM MORPHOGENESIS 20 66 0.001374 0.006511
982 POSITIVE REGULATION OF PROTEIN IMPORT 28 104 0.001372 0.006511
983 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 62 282 0.001376 0.006511
984 CIRCADIAN REGULATION OF GENE EXPRESSION 18 57 0.001392 0.006575
985 MYOTUBE DIFFERENTIATION 18 57 0.001392 0.006575
986 REGULATION OF CAMP METABOLIC PROCESS 33 129 0.001406 0.006635
987 GLUCOSE HOMEOSTASIS 41 170 0.001412 0.00665
988 CARBOHYDRATE HOMEOSTASIS 41 170 0.001412 0.00665
989 EMBRYONIC HEMOPOIESIS 9 20 0.001431 0.006711
990 RELAXATION OF MUSCLE 9 20 0.001431 0.006711
991 INTRACELLULAR LIPID TRANSPORT 9 20 0.001431 0.006711
992 REGULATION OF RECEPTOR RECYCLING 9 20 0.001431 0.006711
993 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 0.001444 0.006767
994 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 24 85 0.001451 0.006792
995 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 21 71 0.001485 0.006945
996 NEUROTRANSMITTER TRANSPORT 38 155 0.001507 0.007017
997 MIDBRAIN DEVELOPMENT 25 90 0.001505 0.007017
998 REGULATION OF CELL PROJECTION ASSEMBLY 38 155 0.001507 0.007017
999 REGULATION OF GLIOGENESIS 25 90 0.001505 0.007017
1000 INORGANIC ION TRANSMEMBRANE TRANSPORT 115 583 0.001522 0.007083
1001 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 17 53 0.001545 0.007155
1002 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 17 53 0.001545 0.007155
1003 FORELIMB MORPHOGENESIS 14 40 0.001545 0.007155
1004 MESONEPHRIC TUBULE MORPHOGENESIS 17 53 0.001545 0.007155
1005 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 103 514 0.001544 0.007155
1006 REGULATION OF DEFENSE RESPONSE 145 759 0.001578 0.0073
1007 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 10 24 0.001604 0.007403
1008 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 10 24 0.001604 0.007403
1009 OLFACTORY LOBE DEVELOPMENT 13 36 0.001628 0.007498
1010 SEMAPHORIN PLEXIN SIGNALING PATHWAY 13 36 0.001628 0.007498
1011 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 11 28 0.001677 0.00769
1012 PATTERNING OF BLOOD VESSELS 12 32 0.001677 0.00769
1013 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 12 32 0.001677 0.00769
1014 REGULATION OF SPROUTING ANGIOGENESIS 11 28 0.001677 0.00769
1015 PURINERGIC RECEPTOR SIGNALING PATHWAY 11 28 0.001677 0.00769
1016 REGULATION OF IMMUNE EFFECTOR PROCESS 87 424 0.001693 0.007753
1017 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 16 49 0.001705 0.0078
1018 POSITIVE REGULATION OF DNA REPLICATION 24 86 0.001728 0.007899
1019 RESPONSE TO ESTRADIOL 36 146 0.001773 0.008098
1020 RESPONSE TO BIOTIC STIMULUS 166 886 0.0018 0.008213
1021 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 97 482 0.001812 0.008258
1022 POSITIVE REGULATION OF CYTOKINE SECRETION 26 96 0.001822 0.008288
1023 REGULATION OF LEUKOCYTE CHEMOTAXIS 26 96 0.001822 0.008288
1024 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 34 136 0.001829 0.00831
1025 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 27 101 0.001852 0.008376
1026 BRANCH ELONGATION OF AN EPITHELIUM 8 17 0.00186 0.008376
1027 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 0.00186 0.008376
1028 REGULATION OF PROTEIN KINASE A SIGNALING 8 17 0.00186 0.008376
1029 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 8 17 0.00186 0.008376
1030 NEGATIVE REGULATION OF BINDING 33 131 0.001851 0.008376
1031 NEGATIVE REGULATION OF LIPID STORAGE 8 17 0.00186 0.008376
1032 DEFINITIVE HEMOPOIESIS 8 17 0.00186 0.008376
1033 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 8 17 0.00186 0.008376
1034 ENDOTHELIAL CELL DEVELOPMENT 15 45 0.001866 0.008383
1035 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 15 45 0.001866 0.008383
1036 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 15 45 0.001866 0.008383
1037 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 31 121 0.001879 0.008431
1038 VENTRICULAR SEPTUM DEVELOPMENT 17 54 0.001941 0.008702
1039 KIDNEY MORPHOGENESIS 23 82 0.001983 0.008883
1040 REGULATION OF LIPID STORAGE 14 41 0.002023 0.009053
1041 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 24 87 0.002049 0.009158
1042 REGULATION OF PHAGOCYTOSIS 20 68 0.002051 0.009158
1043 REGULATION OF LEUKOCYTE DIFFERENTIATION 52 232 0.002077 0.009264
1044 REGULATION OF PROTEIN CATABOLIC PROCESS 81 393 0.002102 0.009368
1045 POSITIVE REGULATION OF PROTEIN BINDING 21 73 0.002174 0.009527
1046 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 16 50 0.002159 0.009527
1047 DENDRITIC CELL MIGRATION 9 21 0.002169 0.009527
1048 CORONARY VASCULATURE DEVELOPMENT 13 37 0.002165 0.009527
1049 REGULATION OF ORGANIC ACID TRANSPORT 16 50 0.002159 0.009527
1050 MATING 13 37 0.002165 0.009527
1051 POSITIVE REGULATION OF STAT CASCADE 21 73 0.002174 0.009527
1052 REGULATION OF COENZYME METABOLIC PROCESS 16 50 0.002159 0.009527
1053 REGULATION OF MEMBRANE LIPID DISTRIBUTION 13 37 0.002165 0.009527
1054 PANCREAS DEVELOPMENT 21 73 0.002174 0.009527
1055 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 9 21 0.002169 0.009527
1056 REGULATION OF DEPHOSPHORYLATION 38 158 0.002174 0.009527
1057 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 21 0.002169 0.009527
1058 REGULATION OF COFACTOR METABOLIC PROCESS 16 50 0.002159 0.009527
1059 IMPORT INTO CELL 13 37 0.002165 0.009527
1060 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 16 50 0.002159 0.009527
1061 POSITIVE REGULATION OF JAK STAT CASCADE 21 73 0.002174 0.009527
1062 SIALYLATION 9 21 0.002169 0.009527
1063 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 48 211 0.002194 0.009604
1064 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 37 153 0.002228 0.009741
1065 NEGATIVE REGULATION OF JNK CASCADE 12 33 0.002277 0.009946
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 231 819 1.276e-22 1.186e-19
2 ACTIN BINDING 133 393 1.147e-20 3.715e-18
3 MOLECULAR FUNCTION REGULATOR 331 1353 1.2e-20 3.715e-18
4 RECEPTOR BINDING 351 1476 1.001e-19 2.325e-17
5 ENZYME BINDING 394 1737 2.44e-18 4.534e-16
6 PROTEIN COMPLEX BINDING 232 935 2.16e-15 3.345e-13
7 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 82 228 6.214e-15 8.247e-13
8 MACROMOLECULAR COMPLEX BINDING 316 1399 1.608e-14 1.867e-12
9 GROWTH FACTOR BINDING 54 123 2.135e-14 2.204e-12
10 GLYCOSAMINOGLYCAN BINDING 73 205 3.348e-13 3.111e-11
11 CALCIUM ION BINDING 176 697 1.236e-12 1.044e-10
12 KINASE ACTIVITY 204 842 1.353e-12 1.048e-10
13 PROTEIN DOMAIN SPECIFIC BINDING 161 624 1.82e-12 1.301e-10
14 PROTEIN KINASE ACTIVITY 164 640 2.062e-12 1.369e-10
15 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 93 303 4.854e-12 3.006e-10
16 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 160 629 7.233e-12 4.107e-10
17 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 98 328 7.516e-12 4.107e-10
18 KINASE BINDING 155 606 9.849e-12 5.083e-10
19 HEPARIN BINDING 58 157 1.586e-11 7.755e-10
20 SULFUR COMPOUND BINDING 76 234 2.124e-11 9.828e-10
21 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 97 329 2.222e-11 9.828e-10
22 ENZYME REGULATOR ACTIVITY 219 959 8.306e-11 3.507e-09
23 CELL ADHESION MOLECULE BINDING 63 186 1.544e-10 6.235e-09
24 IDENTICAL PROTEIN BINDING 263 1209 2.032e-10 7.865e-09
25 REGULATORY REGION NUCLEIC ACID BINDING 189 818 6.444e-10 2.395e-08
26 PROTEIN DIMERIZATION ACTIVITY 249 1149 9.35e-10 3.341e-08
27 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 220 992 1.195e-09 4.112e-08
28 SMAD BINDING 32 72 2.837e-09 9.088e-08
29 ENZYME ACTIVATOR ACTIVITY 120 471 2.824e-09 9.088e-08
30 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 88 315 3.601e-09 1.115e-07
31 CYTOKINE BINDING 37 92 4.999e-09 1.498e-07
32 CALMODULIN BINDING 58 179 5.361e-09 1.556e-07
33 PROTEIN HOMODIMERIZATION ACTIVITY 167 722 6.049e-09 1.703e-07
34 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 253 1199 9.153e-09 2.501e-07
35 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 33 81 2.283e-08 6.061e-07
36 BINDING BRIDGING 55 173 2.772e-08 7.153e-07
37 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 29 70 1.035e-07 2.599e-06
38 TRANSFORMING GROWTH FACTOR BETA BINDING 12 16 1.451e-07 3.546e-06
39 SH3 DOMAIN BINDING 40 116 1.897e-07 4.52e-06
40 ACTIN FILAMENT BINDING 41 121 2.31e-07 5.365e-06
41 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 64 226 2.751e-07 6.232e-06
42 INTEGRIN BINDING 37 105 2.897e-07 6.407e-06
43 SIGNAL TRANSDUCER ACTIVITY 336 1731 3.391e-07 7.326e-06
44 SIGNALING ADAPTOR ACTIVITY 29 74 4.287e-07 9.051e-06
45 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 51 168 4.393e-07 9.068e-06
46 ION CHANNEL BINDING 38 111 4.688e-07 9.469e-06
47 CATION CHANNEL ACTIVITY 78 298 5.157e-07 1.019e-05
48 TRANSCRIPTION FACTOR BINDING 121 524 8.239e-07 1.595e-05
49 RECEPTOR SIGNALING PROTEIN ACTIVITY 51 172 9.696e-07 1.838e-05
50 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 132 588 1.341e-06 2.492e-05
51 PROTEIN SERINE THREONINE KINASE ACTIVITY 105 445 1.524e-06 2.776e-05
52 LIPID BINDING 144 657 1.866e-06 3.333e-05
53 PROTEIN TYROSINE KINASE ACTIVITY 51 176 2.059e-06 3.61e-05
54 ZINC ION BINDING 232 1155 2.136e-06 3.675e-05
55 RIBONUCLEOTIDE BINDING 352 1860 2.208e-06 3.73e-05
56 PHOSPHOLIPID BINDING 88 360 2.319e-06 3.847e-05
57 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 25 64 2.83e-06 4.612e-05
58 PHOSPHORIC ESTER HYDROLASE ACTIVITY 89 368 3.253e-06 5.122e-05
59 TRANSITION METAL ION BINDING 273 1400 3.245e-06 5.122e-05
60 DOUBLE STRANDED DNA BINDING 162 764 3.446e-06 5.249e-05
61 CYTOKINE RECEPTOR ACTIVITY 31 89 3.43e-06 5.249e-05
62 GTPASE BINDING 73 295 1.037e-05 0.0001553
63 WNT PROTEIN BINDING 15 31 1.326e-05 0.0001906
64 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 30 90 1.333e-05 0.0001906
65 CORECEPTOR ACTIVITY 17 38 1.325e-05 0.0001906
66 COLLAGEN BINDING 24 65 1.384e-05 0.0001948
67 PROTEIN KINASE A BINDING 18 42 1.538e-05 0.0002132
68 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 104 464 1.847e-05 0.0002524
69 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 33 105 2.04e-05 0.0002747
70 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 95 417 2.137e-05 0.0002836
71 GROWTH FACTOR RECEPTOR BINDING 38 129 2.62e-05 0.0003428
72 ACTININ BINDING 14 29 2.667e-05 0.0003441
73 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 26 76 2.948e-05 0.0003751
74 KINASE INHIBITOR ACTIVITY 29 89 2.994e-05 0.0003759
75 GATED CHANNEL ACTIVITY 77 325 3.109e-05 0.0003852
76 CHANNEL REGULATOR ACTIVITY 38 131 3.817e-05 0.0004666
77 SULFURIC ESTER HYDROLASE ACTIVITY 10 17 4.407e-05 0.0005317
78 HORMONE BINDING 23 65 4.565e-05 0.0005437
79 ACTIVATING TRANSCRIPTION FACTOR BINDING 21 57 4.88e-05 0.0005667
80 SEQUENCE SPECIFIC DNA BINDING 203 1037 4.845e-05 0.0005667
81 ALPHA ACTININ BINDING 11 21 7.686e-05 0.000875
82 ARYLSULFATASE ACTIVITY 8 12 7.723e-05 0.000875
83 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 8.768e-05 0.0009583
84 STEROID HORMONE RECEPTOR ACTIVITY 21 59 8.748e-05 0.0009583
85 HISTONE ACETYLTRANSFERASE BINDING 13 28 8.638e-05 0.0009583
86 EXTRACELLULAR MATRIX BINDING 19 51 9.268e-05 0.001001
87 VOLTAGE GATED ION CHANNEL ACTIVITY 49 190 9.401e-05 0.001004
88 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 28 90 0.0001023 0.00108
89 TUBULIN BINDING 65 273 0.0001063 0.001109
90 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 25 77 0.0001103 0.001138
91 PEPTIDE HORMONE BINDING 15 36 0.0001157 0.001182
92 RECEPTOR ACTIVITY 303 1649 0.000119 0.001202
93 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 36 128 0.0001211 0.00121
94 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 44 167 0.0001234 0.001219
95 WNT ACTIVATED RECEPTOR ACTIVITY 11 22 0.0001327 0.001297
96 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 46 178 0.0001437 0.001391
97 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 30 101 0.0001505 0.001442
98 NITRIC OXIDE SYNTHASE BINDING 10 19 0.0001563 0.001481
99 GTPASE ACTIVITY 59 246 0.0001751 0.001643
100 ADENYL NUCLEOTIDE BINDING 279 1514 0.0001836 0.001706
101 GROWTH FACTOR ACTIVITY 42 160 0.0001895 0.001743
102 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 30 103 0.0002209 0.002012
103 G PROTEIN COUPLED RECEPTOR BINDING 61 259 0.0002332 0.002103
104 CORE PROMOTER BINDING 40 152 0.0002513 0.002245
105 PROTEIN COMPLEX SCAFFOLD 22 68 0.0002949 0.002609
106 AMIDE BINDING 63 272 0.0003031 0.002657
107 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 16 43 0.0003318 0.002881
108 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 0.0003436 0.002955
109 GLUCOCORTICOID RECEPTOR BINDING 8 14 0.000352 0.002972
110 NEUREXIN FAMILY PROTEIN BINDING 8 14 0.000352 0.002972
111 GLYCOPROTEIN BINDING 29 101 0.0003637 0.003044
112 RHO GTPASE BINDING 24 78 0.0003737 0.0031
113 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 27 92 0.0003899 0.003205
114 MICROTUBULE BINDING 49 201 0.0003984 0.003246
115 KINASE REGULATOR ACTIVITY 46 186 0.0004207 0.003398
116 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 17 48 0.0004304 0.003418
117 PHOSPHOLIPID TRANSPORTER ACTIVITY 17 48 0.0004304 0.003418
118 PROTEIN HETERODIMERIZATION ACTIVITY 98 468 0.0004431 0.003459
119 GUANYL NUCLEOTIDE BINDING 84 390 0.0004428 0.003459
120 VIRUS RECEPTOR ACTIVITY 22 70 0.0004654 0.003603
121 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 0.0005397 0.004143
122 CORE PROMOTER PROXIMAL REGION DNA BINDING 80 371 0.0005757 0.004384
123 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 35 133 0.000592 0.004471
124 PHOSPHATIDYLINOSITOL BINDING 48 200 0.0006582 0.004837
125 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 8 15 0.000654 0.004837
126 PDZ DOMAIN BINDING 26 90 0.0006458 0.004837
127 TRANSCRIPTION COREPRESSOR ACTIVITY 52 221 0.0006613 0.004837
128 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 17 50 0.000739 0.005364
129 RAB GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 12 30 0.0008621 0.006208
130 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 17 51 0.0009538 0.006816
131 METALLOPEPTIDASE ACTIVITY 45 188 0.001009 0.007157
132 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 8 16 0.001135 0.007985
133 CHEMOREPELLENT ACTIVITY 11 27 0.001178 0.00823
134 METALLOENDOPEPTIDASE ACTIVITY 30 113 0.001206 0.008364
135 SH3 SH2 ADAPTOR ACTIVITY 17 52 0.001219 0.008392
136 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 28 104 0.001372 0.009374
137 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 9 20 0.001431 0.009701
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 434 1786 1.617e-26 9.446e-24
2 NEURON PROJECTION 261 942 3.032e-24 8.853e-22
3 SYNAPSE 221 754 5.221e-24 1.016e-21
4 NEURON PART 324 1265 1.232e-23 1.799e-21
5 INTRINSIC COMPONENT OF PLASMA MEMBRANE 394 1649 1.492e-22 1.743e-20
6 EXTRACELLULAR MATRIX 144 426 3.188e-22 3.103e-20
7 PROTEINACEOUS EXTRACELLULAR MATRIX 127 356 4.938e-22 4.12e-20
8 CELL JUNCTION 296 1151 6.742e-22 4.922e-20
9 MEMBRANE REGION 290 1134 4.477e-21 2.905e-19
10 POSTSYNAPSE 123 378 1.156e-17 6.75e-16
11 EXTRACELLULAR MATRIX COMPONENT 58 125 1.035e-16 4.648e-15
12 SYNAPSE PART 171 610 1.031e-16 4.648e-15
13 PLASMA MEMBRANE PROTEIN COMPLEX 150 510 9.11e-17 4.648e-15
14 PLASMA MEMBRANE REGION 231 929 1.938e-15 8.083e-14
15 CELL SURFACE 197 757 2.149e-15 8.367e-14
16 ACTIN CYTOSKELETON 132 444 2.638e-15 9.627e-14
17 MEMBRANE MICRODOMAIN 95 288 2.336e-14 7.859e-13
18 CELL LEADING EDGE 109 350 2.422e-14 7.859e-13
19 SOMATODENDRITIC COMPARTMENT 171 650 5.853e-14 1.799e-12
20 EXCITATORY SYNAPSE 72 197 1.091e-13 3.186e-12
21 DENDRITE 129 451 1.315e-13 3.658e-12
22 CELL SUBSTRATE JUNCTION 117 398 2.402e-13 6.377e-12
23 ANCHORING JUNCTION 136 489 2.917e-13 7.408e-12
24 CYTOSKELETON 406 1967 4.09e-12 9.953e-11
25 I BAND 49 121 1.273e-11 2.973e-10
26 AXON 116 418 1.925e-11 4.324e-10
27 INTRACELLULAR VESICLE 275 1259 4.786e-11 1.035e-09
28 BASEMENT MEMBRANE 40 93 1.061e-10 2.213e-09
29 SIDE OF MEMBRANE 115 428 2.068e-10 4.165e-09
30 RECEPTOR COMPLEX 93 327 4.736e-10 9.219e-09
31 CELL PROJECTION PART 213 946 5.68e-10 1.07e-08
32 CONTRACTILE FIBER 67 211 9.402e-10 1.716e-08
33 GOLGI APPARATUS 301 1445 1.312e-09 2.322e-08
34 SYNAPTIC MEMBRANE 77 261 2.438e-09 4.187e-08
35 ACTOMYOSIN 29 62 3.648e-09 6.088e-08
36 PLASMA MEMBRANE RAFT 35 86 8.932e-09 1.449e-07
37 EXTRINSIC COMPONENT OF MEMBRANE 73 252 1.47e-08 2.32e-07
38 SITE OF POLARIZED GROWTH 50 149 1.649e-08 2.535e-07
39 SARCOLEMMA 44 125 2.353e-08 3.524e-07
40 POSTSYNAPTIC MEMBRANE 62 205 3.087e-08 4.486e-07
41 CELL CELL JUNCTION 99 383 3.15e-08 4.486e-07
42 CELL CORTEX 69 238 3.49e-08 4.852e-07
43 FILOPODIUM 36 94 3.658e-08 4.968e-07
44 CYTOPLASMIC REGION 79 287 4.491e-08 5.961e-07
45 LAMELLIPODIUM 54 172 5.927e-08 7.692e-07
46 COMPLEX OF COLLAGEN TRIMERS 15 23 7.264e-08 9.223e-07
47 VACUOLE 244 1180 1.032e-07 1.283e-06
48 PLATELET ALPHA GRANULE 30 75 1.598e-07 1.944e-06
49 EXTRACELLULAR SPACE 277 1376 1.697e-07 2.022e-06
50 CELL BODY 118 494 1.768e-07 2.065e-06
51 COLLAGEN TRIMER 33 88 2.391e-07 2.737e-06
52 CYTOPLASMIC SIDE OF MEMBRANE 52 170 2.61e-07 2.932e-06
53 ACTIN BASED CELL PROJECTION 54 181 3.796e-07 4.183e-06
54 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 35 98 4.152e-07 4.491e-06
55 RUFFLE 48 156 6.117e-07 6.496e-06
56 ACTIN FILAMENT BUNDLE 24 57 9.007e-07 9.393e-06
57 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 43 136 1.028e-06 1.053e-05
58 MEMBRANE PROTEIN COMPLEX 209 1020 1.718e-06 1.729e-05
59 AXON PART 60 219 2.114e-06 2.093e-05
60 ENDOPLASMIC RETICULUM LUMEN 56 201 2.597e-06 2.516e-05
61 T TUBULE 20 45 2.628e-06 2.516e-05
62 NEURONAL POSTSYNAPTIC DENSITY 22 53 3.392e-06 3.195e-05
63 CYTOPLASMIC VESICLE PART 132 601 4.447e-06 4.122e-05
64 CATION CHANNEL COMPLEX 48 167 5.189e-06 4.735e-05
65 ACTIN FILAMENT 26 70 5.415e-06 4.865e-05
66 INTERCALATED DISC 21 51 6.569e-06 5.813e-05
67 PLATELET ALPHA GRANULE LUMEN 22 55 7.013e-06 6.113e-05
68 CELL CELL CONTACT ZONE 24 64 1.018e-05 8.746e-05
69 A BAND 16 34 1.073e-05 9.078e-05
70 GLYCOPROTEIN COMPLEX 12 21 1.11e-05 9.264e-05
71 PERINUCLEAR REGION OF CYTOPLASM 137 642 1.39e-05 0.0001127
72 SECRETORY VESICLE 104 461 1.385e-05 0.0001127
73 ENDOSOME 163 793 2.002e-05 0.0001602
74 PLASMA MEMBRANE RECEPTOR COMPLEX 48 175 2.045e-05 0.0001614
75 ENDOPLASMIC RETICULUM 305 1631 2.953e-05 0.0002299
76 PODOSOME 12 23 3.794e-05 0.0002915
77 INTERSTITIAL MATRIX 9 14 4.055e-05 0.0003075
78 CELL CORTEX PART 35 119 5.547e-05 0.0004153
79 LEADING EDGE MEMBRANE 38 134 6.561e-05 0.000485
80 M BAND 11 21 7.686e-05 0.0005611
81 NEURON SPINE 35 121 8.073e-05 0.000582
82 SECRETORY GRANULE 80 352 0.0001001 0.000708
83 PRESYNAPSE 67 283 0.0001006 0.000708
84 CYTOSKELETAL PART 268 1436 0.0001055 0.0007333
85 EXTERNAL SIDE OF PLASMA MEMBRANE 58 238 0.0001253 0.0008608
86 EARLY ENDOSOME 70 301 0.0001276 0.0008667
87 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 13 30 0.0002051 0.001377
88 MAIN AXON 20 58 0.0002102 0.001395
89 NEUROMUSCULAR JUNCTION 19 54 0.0002227 0.001461
90 SECRETORY GRANULE LUMEN 26 85 0.0002414 0.001566
91 VESICLE MEMBRANE 107 512 0.000269 0.001727
92 CELL PROJECTION MEMBRANE 68 298 0.0002827 0.001795
93 VOLTAGE GATED SODIUM CHANNEL COMPLEX 8 14 0.000352 0.00221
94 APICAL PART OF CELL 79 361 0.0003894 0.002419
95 GOLGI APPARATUS PART 172 893 0.0004099 0.00252
96 TRANSPORTER COMPLEX 71 321 0.0005449 0.003315
97 VACUOLAR PART 137 694 0.0005552 0.003343
98 APICAL JUNCTION COMPLEX 34 128 0.0005867 0.003496
99 CORTICAL ACTIN CYTOSKELETON 19 58 0.0006264 0.003695
100 NEURON PROJECTION TERMINUS 34 129 0.0006824 0.003982
101 CORTICAL CYTOSKELETON 24 81 0.0006887 0.003982
102 BANDED COLLAGEN FIBRIL 7 12 0.0007165 0.004102
103 VESICLE LUMEN 29 106 0.0008637 0.004897
104 ANCHORED COMPONENT OF MEMBRANE 38 152 0.001025 0.005755
105 RUFFLE MEMBRANE 23 80 0.001385 0.007705
106 FILAMENTOUS ACTIN 9 20 0.001431 0.007882
107 POTASSIUM CHANNEL COMPLEX 25 90 0.001505 0.008214
108 ENDOCYTIC VESICLE 57 256 0.001543 0.008343
109 COATED PIT 20 67 0.001684 0.009022
110 GOLGI MEMBRANE 135 703 0.001841 0.009774
111 SODIUM CHANNEL COMPLEX 8 17 0.00186 0.009784

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 75 199 5.104e-15 2.654e-13
2 MAPK_signaling_pathway_hsa04010 96 295 4.378e-14 1.138e-12
3 cGMP_PKG_signaling_pathway_hsa04022 63 163 2.007e-13 3.478e-12
4 PI3K_Akt_signaling_pathway_hsa04151 105 352 1.504e-12 1.956e-11
5 Regulation_of_actin_cytoskeleton_hsa04810 65 208 3.429e-09 3.566e-08
6 Ras_signaling_pathway_hsa04014 70 232 4.564e-09 3.955e-08
7 FoxO_signaling_pathway_hsa04068 46 132 1.63e-08 1.211e-07
8 cAMP_signaling_pathway_hsa04024 61 198 1.864e-08 1.212e-07
9 ECM_receptor_interaction_hsa04512 33 82 3.268e-08 1.888e-07
10 Rap1_signaling_pathway_hsa04015 62 206 3.771e-08 1.961e-07
11 Apelin_signaling_pathway_hsa04371 46 137 5.958e-08 2.817e-07
12 Phospholipase_D_signaling_pathway_hsa04072 48 146 6.527e-08 2.828e-07
13 Hippo_signaling_pathway_hsa04390 48 154 4.005e-07 1.602e-06
14 Calcium_signaling_pathway_hsa04020 54 182 4.61e-07 1.702e-06
15 Wnt_signaling_pathway_hsa04310 46 146 4.91e-07 1.702e-06
16 Cytokine_cytokine_receptor_interaction_hsa04060 72 270 6.561e-07 2.132e-06
17 Sphingolipid_signaling_pathway_hsa04071 39 118 9.273e-07 2.837e-06
18 Cell_adhesion_molecules_.CAMs._hsa04514 45 145 1.041e-06 3.007e-06
19 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 43 139 1.968e-06 5.306e-06
20 Jak_STAT_signaling_pathway_hsa04630 48 162 2.041e-06 5.306e-06
21 TGF_beta_signaling_pathway_hsa04350 30 84 2.723e-06 6.744e-06
22 Cellular_senescence_hsa04218 45 160 1.848e-05 4.369e-05
23 Adherens_junction_hsa04520 24 72 9.431e-05 0.0002132
24 Phagosome_hsa04145 41 152 0.0001186 0.000257
25 Gap_junction_hsa04540 27 88 0.0001748 0.0003637
26 AMPK_signaling_pathway_hsa04152 34 121 0.0001879 0.0003759
27 ErbB_signaling_pathway_hsa04012 26 85 0.0002414 0.0004649
28 Tight_junction_hsa04530 43 170 0.0003829 0.0007111
29 TNF_signaling_pathway_hsa04668 30 108 0.000539 0.0009665
30 Phosphatidylinositol_signaling_system_hsa04070 27 99 0.001345 0.002332
31 HIF_1_signaling_pathway_hsa04066 27 100 0.001581 0.002653
32 Hippo_signaling_pathway_multiple_species_hsa04392 11 29 0.002336 0.003796
33 Oocyte_meiosis_hsa04114 31 124 0.002832 0.004462
34 mTOR_signaling_pathway_hsa04150 36 151 0.003267 0.004996
35 Neuroactive_ligand_receptor_interaction_hsa04080 56 278 0.01463 0.02146
36 Endocytosis_hsa04144 50 244 0.01485 0.02146
37 Mitophagy_animal_hsa04137 16 65 0.0309 0.04343
38 ABC_transporters_hsa02010 12 45 0.03238 0.04432
39 Hedgehog_signaling_pathway_hsa04340 12 47 0.04419 0.05892
40 VEGF_signaling_pathway_hsa04370 14 59 0.05495 0.07144
41 Apoptosis_hsa04210 28 138 0.06276 0.0796
42 Autophagy_animal_hsa04140 26 128 0.07006 0.08674
43 NF_kappa_B_signaling_pathway_hsa04064 20 95 0.07634 0.09232
44 Necroptosis_hsa04217 31 164 0.1112 0.1315
45 p53_signaling_pathway_hsa04115 14 68 0.1409 0.1628
46 Ferroptosis_hsa04216 8 40 0.2535 0.2866
47 Apoptosis_multiple_species_hsa04215 6 33 0.3845 0.4254
48 Lysosome_hsa04142 20 123 0.4047 0.4385
49 Notch_signaling_pathway_hsa04330 8 48 0.4461 0.4734
50 Cell_cycle_hsa04110 18 124 0.6184 0.6431
51 Autophagy_other_hsa04136 3 32 0.8833 0.8996
52 Peroxisome_hsa04146 9 83 0.8996 0.8996

Quest ID: 87277462f9599ec525065b2aa50604a4